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Abstract 
 
REVERSE-PHASE ION-PAIRING ULTRA PERFORMANCE LIQUID 
CHROMATOGRAPHY-MASS SPECTROMETRY IN CHARACTERIZATION AND 
FINGERPRINTING OF DIVERSE SULFATED GLYCOSAMINOGLYCAN 
MIMETICS 
POOJA PONNUSAMY M. S. 
A thesis submitted in partial fulfillment of the requirements for the degree of 
Master of Science at Virginia Commonwealth University 
Virginia Commonwealth University, 2013 
Director: Dr. UMESH R. DESAI 
Professor, Department of Medicinal Chemistry 
 
Heparin is a highly sulfated glycosaminoglycan with potent anticoagulant, 
antimetastatic, and anti-inflammatory effects. Polymeric and polyanionic nature of 
heparin makes dosing and side effects a nightmare for healthcare professionals.  
Our laboratory has proposed appropriately designed, small, highly sulfated 
aromatic molecules as potential mimetics of heparin. These easier-to-synthesize small 
molecules have been shown to possess interesting pharmacological and improved 
toxicological profiles. However, the detection and characterization of these highly 
sulfated molecules is challenging. 
A robust RP-IP UPLC-MS method was developed to successfully retain, resolve 
and quantify sulfated non-saccharide GAG mimetics without the requirement of pre- or 
 xvi 
post- column derivatization. Comparative analysis reveals intricate dependence of 
resolution and ionization on the structure of ion-pairing agents. This is the first report 
showing systematic use of MS cone voltage to fingerprint sulfated GAG mimetics, 
perhaps eliminating the need for tandem MS techniques. 
 1 
CHAPTER 1  
Introduction 
 Glycosaminoglycans (GAGs) are a family of linear polysaccharides defined by 
the presence of acidic groups on repeating disaccharide units and found commonly 
associated with cell-surface proteins in mammals.1,2 Examples of GAGs obtained from 
nature include heparan sulfate, chondroitin sulfate, dermatan sulfate, keratan sulfate, 
heparin and others.3 GAGs are found in different parts of the human body such as skin, 
cornea, cartilage, basement membrane etc., and exhibit important roles in cellular growth, 
differentiation, cell death, regulation of coagulation etc.1,2,4,5 Much remains to be 
understood on how they modulate protein function, and this aspect is gaining prominence 
in current studies. Experimental studies on identifying GAG sequences are being 
increasingly approached in order to better understand the structural factors affecting their 
localization in the body and the diversity in their functions. 
Heparan sulfate 
Heparan sulfate (HS) is a linear, variably sulfated polysaccharide chain composed 
of uronic acids alternating with glucosamine units.2,3,6 Uronic acids are sugars with C-6 
hydroxyl group oxidized to a carboxylic acid and can exist in HS as either glucuronic 
acid (uronic acid of glucose) or iduronic acid (C-5 epimer of glucuronic acid). 
Glucosamines, on the other hand, are sugars with C-2 hydroxyl group replaced by an 
amine that could be either acetylated to form acetylglucosamine or sulfated to form 
glucosamine sulfate, both of which are present in HS (see Figure 1.1).  
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Figure 1.1.  Illustration of heparan sulfate; with structures of its four main components. Adapted 
from Bernfield et al., 1999.1 
 
 HS is actually a proteoglycan (PG), found ubiquitously on cell-surfaces, and two 
of which, glypicans and syndecans, have been studied significantly.1 HSPGs are involved 
in diverse processes, some of them being recognition and binding extra-cellular matrix to 
epithelial and endothelial cells; facilitating signaling through activation of seven pass 
transmembrane receptors and tyrosine kinase receptors; providing as a base for 
localization of pathogens to adhere, internalize and replicate in host cells etc.1 
Other GAGs like chondroitin sulfate form the “glycan’ part of aggrecans, 
constituting a major component of cartilage, therefore essential in the treatment of 
cartilage disorders such as osteoarthritis. Dermatan sulfate is a GAG predominantly 
found in mammalian skin, associated with glycoproteins such as fibronectin and heparin 
co-factor II, and is found to be involved in biologically-relevant processes like 
coagulation, cell adhesion, wound healing etc.1,7  
 3 
Heparin 
Heparin is a highly sulfated form of heparan sulfate, whereas HS may have an 
average molecular weight of 50,000 – 100,000, heparin displays an average molecular 
weight of 15000. High levels of sulfate groups in heparin allow for electrostatic 
interactions with numerous proteins, thus accounting for its diverse roles in the body, 
ranging from inhibition of haemostasis to angiogenesis.8-10 In fact, an unfractionated 
mixture of heparin, called unfractionated heparin (UFH), is clinically used as an 
anticoagulant drug. 
 
Figure 1.2. Representative structure of unfractionated heparin (UFH) 
A specific five residue sequence, called heparin pentasaccharide, was identified as 
the functional unit that recognized coagulation enzyme inhibitor, antithrombin (AT).11 
Due to its effective activation of AT and subsequent indirect inhibition of thrombin, 
heparin has been popularly used as an anticoagulant since the 1920s.12 It is being 
gradually been replaced by other anticoagulants such as low molecular weight heparins 
(enoxaparin, tinzaparin), and pentasaccharide (fondaparinux, etc), due to fatal side effects 
associated with its administration.8 The drawbacks of heparin are (1) it can only be 
administered parenterally (2) binding to plasma, endothelium, platelets, macrophages etc, 
resulting in unpredictable clearance and a narrow therapeutic window.8 This causes side 
effects such as bleeding, thrombocytopenia etc.13,14 Such potentially fatal side effects 
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associated with traditional anticoagulation therapy have led to an unprecedented demand 
for an “ideal anticoagulant’, especially since deep vein thrombosis, a coagulation 
disorder, is one of the leading causes of deaths in the world.13-18 
The presence of sulfate groups can be seen as a characteristic feature in most of 
the GAGs discussed above. These sulfate groups, as providers of a highly negatively 
charged surface have been implicated in GAG recognition and binding to diverse ligands 
in the body.2,8,19 If present in excess, as in case of over-sulfated chondroitin sulfate 
(OSCS), a heparin contaminant, can cause severe adverse effects.20 In 2008, 81 people 
died to excessive bleeding and several were left in critical state after administration of 
certain batches of heparin from China which were later found to be contaminated with 
OSCS.21 Hence, characterization of GAGs and determination of degree of sulfation and 
sulfation pattern is crucial to not only understand the complex interactions of GAGs in 
the body and optimize them to give least side-effects but also identify contaminants, 
helping prevent further fatalities. 
Characterization of GAGs 
In a 2011 review on heparin significance and characterization, Jones et al. 
described heparin structure analysis as composing of roughly three steps.22 The first step 
is depolymerization of unfractionated heparin into small units such as disaccharides and 
oligosaccharides via enzymatic or chemical cleavage, second, separation of 
oligosaccharide chains by means of techniques like high pressure liquid chromatography 
(HPLC) and capillary electrophoresis (CE) and lastly, identification of each separated 
component by mass spectrometry (MS), tandem mass spectrometry (MS/MS), or nuclear 
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magnetic resonance (NMR). Hyphenated methods such as HPLC-MS, UPLC-MS, 
HPLC-NMR, and CE-NMR can be used to perform the last two steps together in a single 
run and several studies implementing hyphenated techniques in characterization of 
heparin oligosaccharides (OGs) and low molecular weight heparins (LMWHs) - have 
been extensively reported in literature. 2-4,22  
Step 1: Depolymerization  
In the first step, GAGs are freed from their PGs by hydrazinolysis, followed by N-
acetylation of amine-containing groups. The resultant free GAGs are structurally 
complex chains that need to be broken down or depolymerized to make analysis less 
complicated.23 Greater the extent of GAG depolymerization, shorter is the product chain 
length i.e. complete depolymerization of heparin gives disaccharide units as the final 
product. These disaccharides could be of eight different types 24 (Figure 1.3) and their 
compositional analyses have been reported using MS and MS/MS techniques. On the 
other hand, partial depolymerization results in formation of oligosaccharides, the 
structure analyses of which are more complex and have been reported in literature using 
the above mentioned techniques, with varied degrees of success.22,25,26  
 6 
 
Figure 1.3. Structure of Δ-disaccharides derived from digestion with heparinases I, II and III. 
Abbreviations: Ac, acetyl; ΔUA, 4, 5 unsaturated uronic acid residue; GlcNAc, N-acetyl 
glucosamine; GlcNS, glucosamine-N-sulfate; H, hydrogen; 2S and 6S, 2-O-sulfate and 6-O-
sulfate, respectively; Sulf, sulfate.(Image adapted from Skidmore et al. 2010) 23 
 
Enzymatic depolymerization of heparin GAGs involves β (1→4) bond cleavage 
by bacterial heparinases (or heparin lyases) I, II and III, which differ from one another in 
terms of cleavage sites and site-specificity (see Figure 1.4).22,27 Heparinase III is specific 
for GlcNx (1→4) y, where x= S or Ac and y= IdoA or glucuronic acid, and it is the most 
commonly used enzyme for the depolymerization of heparan sulfate. Chondroitin lyases 
are used in case of depolymerization of CS and hydrolases such as keratanase are used to 
cleave keratan sulfate. Structure alteration is observed by the introduction of double bond 
in the hexuronic acid at the non-reducing end.4 
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Chemical depolymerization involves more than one mechanism, namely, 
oxidation, reductive deamination and β –elimination (see Figure 1.5). Cleavage between 
C-2 and C-3 of IdoA or GlcA residues containing vicinal –OH groups is achieved by the 
addition of oxidizing agents like hydrogen peroxide and Cu(II) acetate/Fe(II) sulfate.28 
Reductive deamination by nitrous acid is pH dependent and results in cleavage of either 
N-unsubstituted glucosamine (at pH= 1.5) or N-sulfated glucosamine (at pH= 4.0) to 
anhydromannose in the reducing terminal.29 In the presence of benzyl halide, C-5 
carboxylic acid of hexuronic acid residue is esterified and introduction of strong base 
ensures abstraction of proton from C-5 carbon, leading to ester group leaving and 
formation of double bond between C-4 and C-5 carbons. The difference between 
enzymatically-derived oligosaccharides (except GAG hydrolase-derived products) and 
chemically-derived OGs (except β -elimination products) is that in case of the former, 
UV absorbance is seen at 232nm  (4,5-unsaturation  in hexuronic acid residue at NRE) 
whereas in the latter, UV-active/fluorescent/radioactive labels are attached at the 
reducing ends of the UV-inactive oligosaccharides (OG), for example, para-nitrophenyl 
hydrazine, biotinylated diaminopyridine, boron dipyrromethene (BODIPY-FL) hydrazide 
etc.24, 30-33 
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Figure 1.4. Depolymerization specificities and products of enzymatic depolymerization of 
heparin and heparan sulfate based on the substitutions at positions X, Y. and Z. (Image adapted 
from Jones et al. 2011) 22 
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Figure 1.5. Depolymerization specificities and products of chemical depolymerization via (a) β-
elimination, (b) reductive deamination, and (c) oxidation of heparin and HS based on the 
substitutions at positions X, Y and Z. (Image adapted from Jones et al. 2011) 22 
 
Step 2: Separation 
UFH, LWMHs and heparin oligosaccharides are essentially mixtures of GAG 
chains diverse in chain lengths, degree of sulfation and sulfation pattern.22 In order to 
characterize these molecules, one must resolve the mixture into its components and then 
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proceed to identifying each component using MS, NMR, MS/MS etc. Direct MS infusion 
of heparin without separation would result in a mass spectrum displaying high noise 
levels, limiting the extent of information that can be gathered.34 Therefore, bulky GAGs 
like heparin and LMWHs (average molecular weights ranging from 5000 to 15000), are 
first depolymerized into oligosaccharides or disaccharides which then are further 
separated or resolved into components based on size, charge, polarity etc before heading 
to structure analysis of each component using techniques like NMR, MS etc. 
Traditionally employed approaches for separation of heparin OGs are capillary 
electrophoresis (CE), Poly acrylamide gel electrophoresis (PAGE) and high pressure 
liquid chromatography (HPLC).22 Size-exclusion chromatography (SEC) may be 
performed to separate depolymerized oligosaccharide mixture into batches based on size 
range and each of these batches or those of interest may be subjected to HPLC or CE 
analysis.35-37 
Capillary electrophoresis  
Capillary electrophoresis (CE) is a highly sensitive separation method that takes 
account of electrophoretic mobilities of analyte components based on the net charge/mass 
ratio. Since GAGs are highly negatively charged, CE is widely used in their analysis.38,39 
It also serves as a useful tool in identifying the presence of contaminants such as OSCS in 
heparin.40 The major advantages of using CE are (1) its high resolving power, (2) 
sensitivity, (3) requirement of small amounts of analyte, (4) ease of switching between 
normal and reverse-polarity conditions (i.e. changing the direction of migration), (5) 
simple UV detection, and (6) capability of being conjugated with other structure 
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determination techniques, e.g., with MS and NMR.38 Exploiting these advantages of CE, 
a number of studies on analysis of heparin, HS and heparin disaccharides and their 
compositional analyses have been performed. GAGs can migrate to the anode in the 
absence of EOF in acidic or low pH conditions; hence reverse-polarity mode is much 
favored.42,43 Owing to its microheterogeneous nature, heparin does not separate well in 
CE and a broad peak is obtained.44 The addition of buffers at high concentrations as 
background electrolytes, for example, 0.6 M lithium phosphate and 0.85 M Tris 
phosphate at low pH values 2.8 and 3, respectively, showed improvement of CE profile 
of heparin. In reverse polarity mode, a broad peak of heparin was resolved so as to 
separate OSCS contaminants from heparin with limits of detection as low as 0.5 to 
0.1%.45 Karamanos et al. resolved hyaluronan and CS disaccharides into their 
differentially sulfated (0-3) components in 14 minutes. The analyte was passed through 
an uncoated fused silica capillary with 15mM sodium dihydrogen orthophosphate buffer 
at pH 3.0 and -20 kV and components could be detected at attomole levels.46 In addition 
to voltage gradient, introducing a pressure gradient between the two electrodes has also 
aided in heparin oligosaccharide analysis. Ruiz-Calero et al. performed compositional 
analysis of 8 heparin disaccharides using 60mM formic acid buffer at pH 3.4 at -15 kV 
and a pressure gradient of 3.45x10-3 MPa.43 
Using normal polarity, Desai et al. successfully separated heparin OGs (di- to 
hexasaccharides) using 10mM sodium borate buffer + 50 mM sodium decyl sulfate 
(SDS) at a pH of 8.8 and 20  kV.47 Pervin et al. separated heparin, HS and CS 
disaccharides by performing CE with 20 mM phosphate buffer (pH 3.48) without 
significant peak tailing or the use of multiple buffers, at reverse polarity mode. However, 
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they also observed that normal polarity mode (using conditions established by Desai et 
al.) was better than reverse polarity CE of heparin OGs of long chain lengths such as 
tetradecasaccharides.42 Also using similar normal polarity conditions, Scapol et al. 
additionally used 50- 100 mM triethylamine (TEA) to ion-pair with DS and HS 
disaccharides and the components in the form of molecule-ion pair adducts were detected 
at 214 nm.48 Detection methods other than UV have been simultaneously explored to 
obtain better sensitivity, for example, Chang et al. used laser-induced fluorescence with 
CE to separate and identify seventeen 2-aminoacridone (AMAC)-labeled GAG 
disaccharides at attomole level, achieving 100 times more sensitivity than CE-UV.49 
As mentioned earlier, CE can be coupled with MS to obtain resolution of heparin 
GAGs and structural analysis of each component in a single run.4 Although CE-MS 
seems like an efficient analytical tool for characterization of heparin GAGs, there are 
many hurdles to this procedure. The buffer salts optimal for CE resolution are usually 
non-volatile and highly concentrated, hence are MS-incompatible due to inability to 
vaporize and form ions in an electrospray MS ionization source. To overcome this issue, 
sheath liquid or a sheath gas needs to be introduced and several parameters such as 
temperature, capillary position and voltage, cone voltage, sheath gas flow etc need to be 
modified in a way such that neither ionization nor analyte structural integrity is 
compromised.4 Duteil et al. were the first to successfully characterize eight heparin 
disaccharides using CE-MS. Volatile ion-pairing ammonium acetate buffer was used for 
CE resolution at normal and reverse polarity modes and MS at positive (50 mM 
ammonium acetate buffer at pH 9.2, sheath liquid composed of 1:1 water/acetonitrile + 3 
mM ammonium formate + 2 mM TEA) and negative mode (530 mM ammonium acetate 
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at pH 3.5, sheath liquid composed of 1:1 water/acetonitrile + 0.1% v/v formic acid ). 50 
Recent applications of CE-MS include frontal analysis CE (FACE) coupled with MS to 
study heparin pentasaccharide interaction with antithrombin II.51 However, due to the 
above mentioned drawbacks and others such as the requirement of skilled personnel to 
assemble as well as efficiently operate CE-MS and poor reproducibility of CE itself, the 
use of this method has not yet achieved mainstream popularity.2,22,43 
CE-NMR is a modern analytical tool that has been successfully used in 
characterization of dansylated amino acids on a nanolitre scale 53 and serum bilurubins 54 
but not much has been done in the structural analysis of GAGs, as yet. 
High-performance liquid chromatography (HPLC) 
HPLC involves the use of high pressures (upto 15000 psi) to drive analyte 
components along with a mobile phase through a column based on their polarities. In 
normal-phase chromatography, the column is made of hydrophilic/polar matrix e.g. silica, 
silica bonded with cyano groups, amino groups etc. and the mobile phase is non-polar, 
for example, n-hexane. Reversed-phase columns are packed with non-polar stationary 
phase while the mobile phase passed through the column is generally polar, wherein polar 
analytes elute earliest. Since heparin GAGs are inherently polar due to the presence of 
acidic sulfate groups, reversed-phase chromatography, in the presence of alkyl 
labels/tags, is more favored than normal-phase chromatography.54,55 Besides, other 
advantages of RPC are better resolution, predictable correlation between molecule shape 
and retention factor etc.4 HPLC can also be performed using ion-exchange 
chromatography wherein molecules are resolved based on charge e.g. strong anion 
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exchange chromatography-HPLC (SAX-HPLC).  Several GAG characterization studies 
have been reported so far, using different types of HPLC. 
Ion-exchange chromatography 
This chromatography technique is based on charges carried by the analyte, as a 
result of which, the analyte would form ionic interactions with oppositely charged 
functional groups covalently bonded to the stationary phase.2,22 Based on the charge type 
of functional groups in the stationary phase, columns could be anion- or cation-
exchangers. In case of GAGs, anion-exchange chromatography is used, where the sulfate 
groups of the GAGs form ionic interactions with positively-charged groups such as 
amines bonded to the stationary phase. Anion-exchange could be weak or strong 
depending on the number of anionic groups bonded onto the column matrix. In one of the 
earliest reports using anion exchange chromatography, Rice et al. separated di- to deca- 
saccharides of heparin (obtained via heparinase depolymerization) based on their degree 
of sulfation (charge-based separation), using SAX-HPLC, after having separated them on 
basis of size by gel permeation chromatography (GPC).56 Much later, Bultel et al. 
separated and identified the degree of sulfation and positions of most sulfates present on 
six heparin hexasaccharides (obtained via nitrous acid depolymerization) using high-
performance anion exchange chromatography coupled with matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. 57 Structural 
information was obtained through MS fragmentation (inter- and intra- ring cleavages) of 
hexasaccharides. Trehy et al. implemented SAX-HPLC and were successful in detecting 
upto 0.03% OSCS and separating impurities like DS from heparin within 25 mins.58  Of 
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late, weak-anion exchange chromatography (WAX-HPLC) has been used to separate and 
identify heparin impurities in a relatively time-efficient manner.22 Limtiaco et al. 
observed that although ion-pairing reversed-phase liquid chromatography with 
tributylamine had been in use to separate heparin OGs, it did not help retain heparin, let 
alone separate impurities.59 Following this, they resorted to weak anion-exchange 
chromatography and soon realized that heparin and OSCS were strongly bound to the 
column and did not elute, hence increased the pH so that less, but still sufficient anions 
remained protonated to interact with heparin.60 On-line 1H-NMR was used to detect 
peaks for DS, heparin and OSCS eluting one after another. In a collaborative effort 
involving seven labs, Hashii et al. were able to separate heparin calcium and heparin 
sodium from OSCS in less than 20 minutes using WAX-HPLC, at detection limits as low 
as 0.025% OSCS.61 
Reversed-phase chromatography (RPC) 
Unlike SAX-HPLC, where methods developed for any type of analyte need to be 
implemented on a single type of column, RPC is a polarity-based method that can be 
carried out using different types of columns e.g. silica-C1, -C6, -C8, -C10, -C18, ethylene 
bridged hybrid particle (BEH)-C18 (see Figure 1.6), BEH-amide, BEH-phenyl, high 
strength silica (HSS)-C18, HSS-phenyl-hexyl , HSS-cyanopropyl, charged surface hybrid 
(CSH)-phenyl hexyl , CSH-fluoro phenyl etc. This makes RPC more versatile and 
preferred over other types of chromatographic methods. These columns not only differ in 
chemistries but also properties like particle shape and size, pore size, pH tolerance etc. 
rendering analyte specificity to each column type. Unlike normal phase liquid 
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chromatography, RPC employs a hydrophobic stationary phase and a hydrophilic mobile 
phase and was introduced to separate hydrophobic analytes, although, it is now the most 
widely used chromatographic method, for all kinds of analytes.  
 
Figure 1.6. Illustration of BEH C-18 column chemistry [waters.com] 
 
RPC of GAGs is faced with issues such as too early elution and poor separation 
due to their highly polar nature. Pre-column derivatization or tagging of GAGs with a 
suitable hydrophobic UV-active/fluorescent entity can result in better RPC separation.4 
As mentioned earlier, UV-inactive heparin oligosaccharides obtained via chemical 
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depolymerization are usually tagged with chromophore or fluorophore labels to aid 
detection. Some of these tags also help in chromatographic separation owing to their 
hydrophobicity. Derivatization with 2-aminoacridone (AMAC), pyridyl amine/2-amino 
pyridine (PA), BODIPY, etc. has been popularly employed in RP-HPLC separation of 
GAGs.2  
 Deakin et al. observed that labelling standard HS disaccharide mixture with 
AMAC resulted in efficient picomolar sensitive RP-HPLC separation on a C18 column 
and fluorescence detection of eight disaccharides.55 Performing compositional analysis 
using two techniques i.e. AMAC-derivatized RP-HPLC and SAX-HPLC of HS GAGs 
(from enzyme digested rat liver PGs) showed better resolution and sharper peaks in case 
of RP-HPLC of AMAC-derivatized GAG disaccharides. RP-HPLC and ESI-TOF MS 
analysis of AMAC-labelled H/HS GAGs has also been useful in studying 
depolymerization mechanism of heparitinases such as heparitinase I.62 Reductive 
amination using fluorescent arylamine tags such as PA has been reported in several RP-
HPLC studies on glycans.2,63,64  
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 Figure 1.7. 2-aminopyridine coupling mechanism proposed by Hase et al.65  
Noting that reductive amination is a tedious process involving harsh conditions 
such as high temperature, low pH etc., which could adversely affect GAG structure in the 
process, Ramsay et al. synthesized O-hydroxylamine and N-hydroxylamine fluorescent 
tags that utilized mild reaction conditions (room temperature) and solvents (water) to 
react with oligosaccharides via controlled reductive hydroxyl-amination and form oximes 
and amines of the saccharides, respectively.66 O-hydroxylamine were found to be suitable 
tags for PAGE chromatography since multiple, readily-interconvertible, isomeric (syn-, 
anti-) oximes were generated, complicating HPLC analysis of heparin monosaccharide, 
but at the same time, could withstand basic conditions and give efficient separation using 
PAGE. On the other hand, N-hydroxylamines were concluded suitable fluorescent tags 
for RP-HPLC separation and ESI-MS detection of enzymatically-derived GAG heparin 
and HS OGs (except in case of N-sulfated GAGs where multiple amination products were 
obtained).  
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Other UV-active tags such as 1-phenyl-3-methyl pyrazolone (PMP) (strong UV 
absorbance at 245 nm) 67 and fluorescent tags; 2-aminobenzoic acid/anthranilic acid  
(AA) 68 and BODIPY 24 have also been successfully used in RP-HPLC-MS based 
separation and structural analysis of GAG di- and oligosaccharides. 
Hydrophilic-interaction liquid chromatography (HILIC) 
HILIC is a liquid-liquid chromatographic method that separates analytes on basis 
of polarity. However, in contrast to RPC, the HILIC stationary phase is usually polar and 
the mobile phase is made of organic or aprotic solvents like acetonitrile, 
tetrehydroformamide etc containing a small amount of water. This water is believed to 
form an aqueous environment on the polar stationary phase, resulting in the partitioning 
of analyte between the stationary phase water layer and the organic mobile phase based 
on its charge and resulting solubility i.e. greater the polarity, higher is the retention.69 
Using this method, GAGs of different charges, i.e. neutral and acidic, can be separated 
and analyzed. Derivatization methods such as reductive amination are employed prior to 
HILIC analysis that uses an amine-bonded stationary phase since the amines (of column) 
could react with aldehyde groups of sugars (at RE) and form Schiff base.2 Commonly 
used columns in the HILIC-based separation of Δ-unsaturated GAG di- and 
oligosaccharides are the amine-bonded and amide-bonded silica columns. As early as 
1979, Lee et al. were able to separate and identify three chondroitinase-digested CS 
disaccharides i.e. ΔDi-0S, ΔDi-4S, ΔDi-6S in 10 minutes at 100 ng LOD, using a 
LiChrosorb NH2 column.70 Oguma et al. subjected HS (from mouse liver, brain and 
tumor tissues) to lyase digestion to get Δ-unsaturated disaccharides and used amino-
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bonded HPLC column to successfully analyze differential compositions of these HS-
derived saccharides.71 They used the same amine-bonded column to perform HILIC-
MS/MS compositional analyses of Δ-unsaturated disaccharides of KS found in different 
bovine parts. i.e. nasal cartilage, brain, cornea and found differences in C6 galactosamine 
degree of sulfation (nasal cartilage> cornea> brain).72  When HILIC is combined with on-
line UV/MS identification techniques, salts such as ammonium formate, sodium 
dihydrogen phosphate etc. are often added as solvent modifiers to increase sensitivity and 
compatibility. Alternatively, amide columns have also been used, as they are less basic 
and do not form Schiff bases with analyte GAGs.73 Amide column HILIC combined with 
negative mode MS was used as an assay to confirm sulfation pattern specificity in AT III 
binding with HS.25 HS hexasaccharides of known sulfation patterns were analyzed using 
HILIC-MS and two of the saccharides were found to bind to AT III, confirming the use 
of this method as a useful assay to study protein-GAG binding and specificity. 
Step 3: Detection 
Nuclear magnetic resonance (NMR) 
NMR is a characterization tool that takes into account the spin frequencies of 
protons or carbon atoms of the analyte to give structural and conformational data. 
Analyte proton (1H) and carbon atom (13C) precessional frequencies in the presence of a 
magnetic field (chemical shifts) are a property of their position relative to other atoms in 
an analyte, an important property exploited in NMR. In case of characterization of 
heparin GAGs, the use of NMR is faced with a number of issues such as: requirement of 
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(1) relatively large amounts of sample, (2) high purity of sample, (3) absence of buffer 
salts or ion-pairing agents etc.4,22 
Single dimension (1-D NMR) is useful in limited compositional analysis of 
heparin GAGs. N-acetylation of glucosamine residue (GlcNAc) in a GAG 
hexasaccharide was first reported by Pervin et al, using 1-D 1H-NMR data.34 Following 
this, they went on to successfully analyze bond connectivities in heparin- derived 
saccharide by performing two-dimensional NMR (2-D 1H-13C NMR), obtaining a more 
thorough picture of GAG structure.74  
Uronic acids in GAGs, especially idorunic acids, cannot be reliably quantified 
using traditional methods like HPLC due to their decomposition into iduronolactones via 
chemical depolymerization. IdoA and GlcA compositions of HS, DS and heparin from 
mammalian and porcine sources were analyzed and reported in 2001 by Sudo et al, using 
3-step solvolysis ( N-desulfation, N-reacetylation, followed by O-desulfation of 
galactosamine residues) and 2-D NMR.75 The solvolysis step eliminated unnecessary 
signals arising from sulfate groups of GalpNAc residues, thereby helped clearly identify 
differential 2-D NMR signals from IdoA-GalpNAc bonds and GluA-GalpNAc bonds. 
Deakin et al. reported the nature of HS and DS interactions with hepatocyte 
growth factor/scatter factor (HGF/SF) using NMR.76 Using gel mobility assay, they had 
previously established the requirement of a disulfated IdoA-containing tri/tetra saccharide 
unit for HS or DS binding interaction with HGF. Performing NMR experiments on 15N- 
labeled HGF variant, NK1, titrated with HS and DS oligosaccharides, they observed that 
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both HS and DS bound HGF at the same binding site, which proved to be fairly flexible 
and independent of sulfation pattern on either GAGs. 
Today, 1-D and 2-D 1H-13C NMR are analytical tools widely used by 
pharmaceutical industries manufacturing heparin and LMWHs, to analyze batch purity 
and identify contamination, if any.77,78 This application of NMR gained prominence after 
its successful use in detecting oversulfated CS (OSCS) in adulterated batches of raw 
heparin imported from China, which resulted in more than 80 deaths in 2008.79 
More recently, heteronuclear single quantum coherence spectroscopy (HSQC) 1H-
15N NMR is being investigated as a tool to characterize heparin OGs, based on their N-
sulfo-glucosamine (GlcNS) sulfamate residue content and relative position. In 2013, 
Langeslay et al. reported pH and temperature-controlled 1H and 15N chemical shifts in 
heparins from various sources and LMWHs such as enoxaparin. Similarly, chemical 
shifts in various depolymerized heparin OG standards (differing in GlcNS sulfamate 
position relative to the NRE as well as its degree of sulfation) were obtained and both 
these data were compared to succesfully correlate GlcNS microenvironments with 1H-15N 
HSQC peaks originating from different heparins and their oligosaccharides.80  
Although NMR is an efficient tool for characterization and can be coupled with 
various separation techniques such as CE, SAX, HPLC etc, the above mentioned 
disadvantages as well as need for skilled workers to perform experiments and interpret 
data pose major hurdles in its day to day applicability.4,22 
Mass spectrometry 
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As the name suggests, “mass spectrometry” is a technique that reveals the identity 
of an unknown compound by giving its accurate mass information. In case of a mixture 
of unknown analytes, their signal intensity on a mass spectrum reflects their quantities 
relative to the greatest ionizable component, usually the solvent. This method of detection 
is applied in diverse areas, be it in the analysis of progress of a chemical/enzymatic 
reaction,81,82 or to identify drugs of abuse from bodily fluids in picomolar amounts.83 In 
contrast to NMR, MS does not require large amounts of sample nor does it require highly 
skilled labor to set up or operate.2 It is a fairly flexible technique that has been 
successfully coupled with majority of separation techniques such as CE, HPLC, SPR, GC 
etc. and can be set up to run more than 1000 samples per day, generating desired results 
in a rapid and convenient manner.84 Therefore, MS finds its utility in qualitative and 
quantitative analysis of simple molecules as well as complex mixtures like heparin 
GAGs. MS involving multiple transitions of parent ions into daughter ions and further on, 
in other words, tandem MS, is an important tool in GAG composition profiling and holds 
great promise in GAG sequencing.2  
In the field of GAG characterization, a lot of MS work has been reported over the 
last 2 decades with a handful of scientific review articles that discuss significant 
developments in this field of research.  
General obstacles faced in MS of GAGs are degradation of analyte in the source 
and subsequent loss in intensity of molecular ion, for example, in hard ionization MS 
techniques such as electron ionization (EI) and fast atom bombardment (FAB).2 Also, in 
soft ionization MS techniques such as matrix-assisted laser desorption ionization 
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(MALDI), in addition to fragmentation, GAGs have been observed to interact with the 
ions in matrices due to their highly polar nature, leading to noisy cationic peaks.2 Several 
studies have reported breakage of glycosidic linkages between GAG saccharides and 
more often, loss of acidic sulfate groups during ionization, formation of cationic (K+, 
Na+) complexes, resulting in a molecular ion of altered identity. Attempts at structure 
elucidation or sequencing by tandem MS of such a parent ion cannot be fruitful. Hence, 
much research has been directed towards overcome this problem, resulting in techniques 
such as ion-pairing, derivatization, peptide-linkage of GAGs etc.  
In 1994, Juhas and Beimann reported the use of peptides to characterize complex 
molecules such as heparin GAGs. By using basic synthetic peptide SP 3 
(IRRERNKMAAAK-SRNRRRELTDTL; molecular weight – 2942.41), and mixing it 
with octasulfated heparin hexsaccharide in 1:1 ratio in a sinapinic acid matrix, they were 
able to successfully eliminate metal counterion signals and obtain molecular ion peaks. 
The peaks showed loss of 1 to 3 sulfate groups, but resultant data was at least indicative 
of the saccharide content and minimum number of sulfate groups.85 Further developments 
in characterization studies of GAGs using MALDI led to changes in the matrix, such as 
use of ionic liquid matrices, introduction of co-matrices such as quaternary ammonium 
salts (Ueki et al) etc.86  These developments helped eliminate unwanted metal K+, Na+ 
adduct ion signals and reduce sulfate losses to a greater extent. 
In addition to MALDI, several reports indicate the use of electrospray ionization 
(ESI) MS for GAG structure determination, sequencing, composition determination 
etc.2,4,22  In ESI, small amounts of sample are mixed with a volatile solvent and 
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introduced into the source in the form of an aerosol spray. High voltage and temperature 
conditions transform the sample into gaseous singly-charged or multi-charged ions, 
which appear on the spectrum as mass/charge peaks. The principle of ESI will be 
discussed in the next section (UPLC-MS).  
ESI-MS-MS involves shooting the parent ion with high energy collision gas, 
causing it to fragment into distinct daughter ions, in a reproducible manner (see Figure 
1.8 for ESI-MS-MS instrumentation).  
 
Figure 1.8. Schematic of an ESI-MS-MS triple quadrupole spectrometer. (Snapshot taken from 
MassLynx 4.1, Acquity TQD mass spectrometer console) 
 
In case of GAGs, fragmentation can result out of glycosidic bond cleavage, cross-
ring cleavages and sulfonate cleavage. Sulfate losses tend to occur more abundantly than 
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other cleavages, resulting in loss of structural information. Ion-pairing these sulfate 
groups with calcium ion has been reported to make GAG sulfonate groups less prone to 
fragmentation than as a sodium or potassium salt.87 ESI-MS, in general, and even 
MALDI, always result in generation of even electron species. A novel route to ensure 
more cross-ring cleavages than sulfate loss, upon MS-MS, is electron detachment 
dissociation (EDD) fragmentation, wherein shooting the parent ion with a beam of 
electrons, results in the generation of an odd-electron species (by the loss of a single 
electron).88-90 Heparin oligosaccharide sequencing tool (HOST), developed by Saad and 
Leary, is capable of automatically generating sequence information from MS-MS data, 
but fails to differentiate between uronic acid epimers.91 
Overcoming this drawback, Wolff et al., in 2007, reported the application of EDD 
in Fourier transform ion cyclotron resonance (FTICR) MS. This method resulted in 
generation of cross-ring and glycosidic bond cleavages in odd electron parent species, 
making it possible to identify sulfation sites as well as differentiate between iduronic and 
glucuronic acid residues in heparin tetrasaccharides.92 
Composition analysis of heparin disaccharide mixture using CID MSn, has 
resulted in identification and quantification of all of the twelve isomers that are generated 
from heparin-lyase digestion (see Figure 1.9 ).93  In order to prevent metal adduct ion 
peaks, ammonium hydroxide was introduced into the 1:1 water: methanol solution 
containing heparinase-digested mixture. MSn of this mixture generated diagnostic 
daughter ions from each disaccharide in reproducible intensities. Such fingerprints are 
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projected to be instrumental in compositional profiling of longer chain heparin 
oligosaccharides. 
 
Figure 1.9. Chemical structures of the 12 disaccharides formed by heparinase I, II, and III 
digestion of heparin and HS are described by the pairwise combination of a roman numeral and a 
non-italicized letter from the table (e.g. IS ≡ ΔUA2S-GlcNS6S). Propionyl groups designated by 
the italicized ‘P’ can be added chemically to generate synthetic standards. (Image adapted from 
Behr et al. 2005).93 
 
Owing to its versatility, MS is widely used, not just alone, but also in combination 
with various chromatographic methods (reversed-phase LC, ion-pairing reversed-phase 
LC, SEC etc) in the structure elucidation of molecules as complex and 
microheterogeneous as heparin GAGs.  
LC-MS of heparin GAGs 
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Both liquid chromatography and mass spectrometry of GAGs have already been 
discussed, in detail, separately, in the previous sections. There are several reports in 
literature that utilize LC-MS for characterization of GAGs.2,4,22 This is mainly because 
both these techniques can be easily hyphenated, relatively easy to operate, highly 
sensitive (upto picomolar sensitivities have been reported) and together, they can be used 
to generate large amounts of data in a single day. For applications, refer back to high 
performance liquid chromatography (HPLC). 
Since in this project, reversed-phase ion-pairing LC-MS was used as our 
characterization tool of choice, the principle, working and applications of this method 
will be discussed in detail, from here on. 
Reversed phase ion-pairing liquid chromatography (RPIP) 
RPIP is a method of RPC where hydrophobic ‘hetaerons’ or ion-pairing agents, 
oppositely charged to the analyte molecule of interest, are introduced into the mobile 
phase in order to form ion-pairs with the target analyte. Formation of these ion-pairs 
renders the analyte hydrophobic enough to retain on the column for longer times 
(retention factor between 5 and 20).94 
Retention factor (k') : This is a simpler, conventional way of representing the 
retention of an analyte in a column than retention time alone. Retention factor takes into 
account the time it takes for the column to flush out the solvent and deducts it from the 
time it takes for the analyte to elute out of the column (see Figure 1.10). The efficiency of 
an LC method/system can be measured by kʹ of the analyte in given column environment. 
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Ideally, k' value should be greater than 5 and less than 20. Any analyte that shows a kʹ < 
5 is poorly retained on the column and if its kʹ > 20 then it is retained too strongly in the 
column.  
 
Figure 1.10. Diagrammatic representation of a typical liquid chromatogram 
Retention factor, 
 
Where, 
t analyte = time taken for the analyte peak to appear on the chromatogram 
t solvent = time taken for the solvent peak to appear on the chomatogram 
Acidic molecules such as heparin GAGs, owing to their hydrophilicity, are poorly 
retained on an RP column, showing kʹ values < 2. A popular method used to overcome 
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this hurdle is RPIP chromatography.  Positively charged ion-pairing agents, such as 
quaternary tetraalkylammonium phosphate has been traditionally used in RPIP LC-MS 
characterization of heparin GAGs and LMWHs.95,96  Unfortunately, with time, quaternary 
amines have been found to be detrimental to the mass spectrometer and can reduce the 
signal-to-noise ratios as they are less volatile in nature.95,97 
Ion-pairing 
Two kinetic mechanisms have been proposed as involved in ion-pairing.98  
1. Interaction of analyte with ion-pairing agent in the mobile phase and subsequent 
adsorption of the analyte-ion pairing agent complex onto the stationary phase.  
2. Adsorption of the ion-pairing agent onto the stationary phase, owing to hydrophobicity 
from alkyl chain(s) of the agent. Analyte then binds to this hydrophobic charged 
stationary phase due to attractive forces between unlike charges, resembling ion-
exchange. Only peak widths (and not retention) are affected by the two mechanisms.98 
During ion-pairing, the column is in a state of dynamic equilibrium, governed by 
several factors.97-99 These thermodynamic factors/processes are in turn believed to affect 
retention in RPIP: 
1. Net charge on the column stationary phase; this is the amount of ion-pairing agent, P, 
adsorbed onto the stationary phase. It is directly dependent on the concentration of P 
in the column and its chain length. Greater the concentration/ chain length, more 
saturated the column is, resulting in greater retention of charged analyte. 
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2. pH; affects RPC and IPRP differently. In case of RPC, an acidic molecule (eg. 
RCOOH), at low pH, would be retained greater (unionized form, RCOOH, is 
hydrophobic and sticks to the stationary phase by means of hydrophobic-hydrophobic 
attraction) and at high pH, the ionized RCOO- form would elute out with less or no 
retention. On the other hand, in IPRP, the stationary phase is now a charged dynamic 
ion-exchanger. At low pH, unionized acidic molecule would elute early/be less 
retained, whereas at high pH (pH > pKa of acidic molecule), deprotonated acidic 
analyte ions would be attracted to oppositely charged ion-pairing agent-coated 
stationary phase and therefore be retained.  
3. Amount of analyte:P complex in the mobile phase; dependent on strength of organic 
mobile phase and concentration flowing through the column. In general a gradient 
elution with increasing organic phase, increases retention, however, if there is too 
much organic phase or if it is of higher strength, then the organic mobile phase may 
actually compete with the hydrophobic stationary phase in their ability to carry 
analyte:P complex. As a result, retention may actually decrease after a plateau is 
reached. 
4. Other factors such as buffers, temperature of the column; buffers help control the pH 
and keep the ion-pairing agents as well as the analytes charged. Reproducibility of 
separations requires constant monitoring and regulation of column temperature. 
 
Electrospray ionization mass spectrometry (ESI-MS) 
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ESI-MS is an MS technique introduced by Dr. John Fenn, 101,102 for which he was 
awarded the Nobel Prize for chemistry in 2002. Electrospray is the phenomenon of liquid 
dispersion as a spray of fine droplets, in other words, an aerosol, under the influence of 
an electric field. As a concept, electrospray had been explored more than a century ago 
by Lord Rayleigh when he proposed the Rayleigh limit for ionic droplets. However, it 
wasn’t until Fenn’s invention, that this phenomenon was used in mass spectrometry. 
Today, a word search on “ESI-MS” gives 10186 hits on PubMed alone, an evidence of 
the popularity of this revolutionary technology. 
While MALDI has no limitation on the mass that can be analyzed, ESI does 
possess a mass limitation (eg. 2048 Da). However, it still can be used to analyze 
macromolecules of high molecular weights, as ESI tends to form multiply charged ions. 
Some of its reported applications in structure analysis of GAGs are listed in the previous 
section - Mass spectrometry. 
Electrospray ionization – principle 
Although some extent of what happens in electrospray ionization is still a mystery 
to scientists, it is known as a combination of electrostatic, electrochemical, and 
thermodynamic processes occurring simultaneously.100,102-105 
As the analyte, mixed with volatile solvent, is infused into the MS source through 
the injection needle, it flows out through a fine capillary maintained at high voltage 
(about 2 – 4 kV) and atmospheric pressure. Such conditions, along with high temperature 
(250 – 450 °C) and nitrogen gas flow (at about 650 L/hr), cause the solvent to evaporate 
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and analyte to be ejected as spray of ionized droplets.   In case of positive mode MS, 
oxidation occurs at the capillary tip, leading to generation of positively charged ions, by 
the loss of electrons. This dynamic electrochemical process is inverted in case of negative 
mode MS. The aerosol spray of ionic droplets ends up as fine singly or multiply charged 
gaseous ions, following any one of the two hypothetical mechanisms 106 explained below. 
1. Charge-residue mechanism :  
The droplets each contain several analyte ions. As they evaporate due to high 
temperature and nitrogen flow, the surface tension of droplets increases, to a point where 
they can no longer sustain repulsive forces within, and explode into fine droplets. This is 
called Rayleigh limit. Each of these fine droplets contains one or more analyte ions 
(charges). Upon further coulombic fission, ultra-fine droplets are formed, remaining 
solvent evaporates and the analyte ions enter gas phase. This mechanism is said to be 
followed by analytes of high masses. 
2. Ion-evaporation mechanism : 
Ultra fine droplets are formed by coulombic fission, just like in charge-residue 
mechanism. Contrarily, however, analytes do not undergo repetitive fissions and solvent 
evaporations to give rise to gaseous ions. In fact, the electric strength of the fine droplets 
reaches a high due to the decrease in size, making it favorable for the analyte ions to 
move from droplet surface, into gaseous phase, to be stable. This mechanism is believed 
to be followed by lower mass analytes. 
 34 
In a typical ESI-MS ionization chamber, the aerosol spray is 90 degrees to the 
skimmer cone, allowing for neutral species to go into waste, instead of being pulled into 
the MS, by means of the cone. The skimmer cone is maintained at voltage that can be 
manually altered. This voltage difference between the capillary and the cone is another 
factor that contributes to the electrospray formation. At the same time, this voltage 
difference as well as that between the skimmer cone and the quadrupole, causes 
fragmentation of ions and subsequent loss of structural information. This is known as up-
front collision-induced dissociation (CID), explained in detail in chapter four. 
 
Figure 1.11. Pictorial representation of Taylor cone formation and 'dragging' of the ions formed 
through a potential gradient (an electric field) to the counter plate. (Image courtesy of Andreas 
Dahlin (www.adorgraphics.com)) 
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Ion-pairing reverse-phase LC-MS of GAGs 
Ion-pairing reversed-phase LC-MS has been widely reported in literature as a 
preferred analytical tool for the structure analysis of complex glycan mixtures such as 
heparin GAGs. 2-4,22 From as early as 1980, quaternary amines have been studied as 
agents that could potentially ion-pair with and separate heparin disaccharides.2 Several 
literature reports show the use of tetraalkylammonium and trialkylamine salts such as 
tetrabutyl ammonium phosphate and tributylamine for the characterization of heparin, 
LWMHs and heparin oligosaccharides.2,107-110 Quantitation of eight disaccharides in 
heparan sulfate and heparin was done using IP-RP microflow HPLC-MS and 12 mM 
tributylamine as the ion-pairing agent. Using radiolabeled glycans as internal standards 
and tandem MS, the quantities of each heparin/ HS disaccharide were calculated and 
compared with mixtures of known disaccharide composition, finding no more than a 
difference of 2 ng between the two.107 Futhermore, disaccharide quantities and 
composition in HS obtained from different sources, such as, porcine liver, bovine brain 
were found, following the same procedure. Thanawiroon et al. used partially (30%) 
digested bovine lung heparin to obtain oligosaccharides of varied chain lengths.108 Using 
15 mM tributylamine along with 50 mM ammonium acetate buffer, they obtained 
resolution of upto di- to tetradeca- saccharide length, under negative MS mode, and peaks 
of upto dp28  length, using positive mode MS. 
 However, non-volatile ion-pairing agents such as tetraalkylammonium cation, 
sulfonate and phosphate anion have been observed to cause mass spectrometric pollution, 
resulting in significant drop in MS sensitivity and reduced signal to noise ratio.95,97 
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Hence, despite their popularity, the use of these agents had to be cut down and other 
agents were investigated. Kuberan et al. found that dibutylamine at 5mM, in comparison 
with other secondary, tertiary and quaternary amines, was optimal for characterizing 
heparin oligosaccharides.111 An ideal ion-pairing agent should not only easily ion-pair 
with analyte, but also be volatile enough to not block the MS source during spray 
formation.  
In other efforts, quaternary and tertiary amines were continued to be used as ion-
pairing agents, but methods to get rid of these counter ions before they reach the MS 
source, were being pursued. This involved using ion-trap MS, introducing sheath liquids, 
valve switching, addition of volatile additives etc. Loss of analyte signal, requirement of 
specialized equipment and skilled personnel etc. are some of the drawbacks of using 
these methods.97 Additives may cause structural and chemical changes in the analyte 
molecule, in turn affecting column retention as well as MS ionization of analyte. 
Rationale 
In the Desai lab, we aim to discover small molecule mimics of heparin, by 
synthesizing on a high-throughput scale, as a positive, much-needed step towards safer 
anti coagulation therapy. Therefore, the characterization of these heparin mimetic 
molecules is imperative to further our research in coagulation therapy. There are, 
however, challenges in this direction. 
As noted previously in this chapter, heparin oligosaccharides not only retain 
minimally in reversed-phase columns but also tend to lose structural information in the 
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MS, by means of sulfonate losses that occur before inter and intra-ring cleavages. Similar 
behavior is exhibited by our mimetic compounds, since they are also sulfated.  
In addition, these sulfated mimetics, owing to their high hydrophilicities, are not retained 
on reversed-phase HPLC column, similar to heparin GAGs. NMR analysis requires large 
amount of sample, does not show the presence of sulfates directly, and is not sensitive to 
small amounts of degradation products in the sample. 
 Literature reports, in the last few decades, indicate that ion-pairing LC-MS has 
shown much promise as the analytical tool of choice in heparin GAG characterization. 
Hence, ion-pairing reversed-phase UPLC-MS was investigated as a method to 
characterize to our library of heparin mimetics. Linear and tertiary amines were tested as 
IPAs, against a library of active molecules, belonging to diverse scaffolds. We examined 
the effect of each IPA on analyte retention, as well as, on its subsequent ionization. These 
results laid foundations to understanding the mechanism of ion-pairing and the factors 
influencing it. 
Also, unique fingerprints of each compound, generated using MS alone, were 
useful in differentiating positional isomers. Futher studies may, perhaps, help us in 
obtaining more structural information, such as the relative positions of sulfate groups in 
an unknown analyte/mixture. 
Agents that gave maximum retention and preserved the analyte’s structural 
integrity with no compromise in MS signal intensity, were chosen for characterization of 
larger, complex biologically active mixtures synthesized in our lab. 
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The focus of this work is the characterization of heparin mimetics by achieving optimal 
retention and MS ionization of intact molecular ions, without ion suppression. At the 
same time, in order to develop a method that is reliable, sensitive and easy-to-use on a 
high-throughput scale, we ensured that no pre-column or post-column modifications are 
required. The RPIP UPLC-MS method aims to be useful in the characterization of larger, 
highly sulfated mixtures, without the requirement for depolymerization or permethylation 
of sulfate groups prior to LC-MS analysis. 
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CHAPTER 2  
Development of Reversed-Phase Ion-Pairing Liquid Chromatography-Mass 
Spectrometric Analysis Of Catechin Sulfate 
                        In 2002, the Desai lab published a study on the design of the first non-saccharide 
activator of antithrombin (AT), known as epicatechin sulfate (ECS).112 ECS, a flavanoid 
with five sulfate groups, was reported to exhibit a strong affinity for AT with Kd ~ 10.7 
μM. In order to understand its binding mode, structurally similar sulfated flavanoids i.e. 
(+) − catechin sulfate (CS) and (±) − catechin sulfate (RCS) were studied. Competition 
assays and molecular docking studies showed that ECS, CS and RCS competed with 
heparin to bind AT at the extended heparin binding site (EHBS) via ionic interactions.  
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Figure 2.1.  (+)-catechin sulfate (CS); (-) - epicatechin sulfate (ECS) 
 CS has since been pursued as a molecule of interest for the following reasons; (1) 
it exhibits heparin mimicking properties; (2) it is non-saccharide based; (3) it has five 
sulfate groups, imparting charge density similar to heparin pentasaccharide (4) is 
homogeneous and hence, is expected to exhibit considerable specificity in its interactions, 
unlike heparin and LMWHs. 
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Several methods have been employed to characterize CS in the past few years, 
each with limitations of its own. In a reverse polarity capillary electrophoretic CS 
analysis by Dantuluri et al., separation of flavanoids (CS and ECS) from flavonoids 
(quercetin and apigenin sulfate) was achieved; however no mass identification was 
attempted.113 This CE method can be used only when the identity and degree of sulfation 
of sample components are known. Disadvantages such as low reproducibility, mar the use 
of CE alone as an analytical tool. With reversed phase LC-MS, CS is not retained on 
either UPLC or the HPLC column due to its high polarity. In addition, MS in-source 
sulfonate losses (as SO3-- Na+ ions) result in mass spectra containing numerous ion 
signals, making it difficult to deduce any useful information. 
Although CS is structurally similar to GAG saccharides in being polysulfated, it 
shows one major difference; it possesses non-saccharide based, i.e., its sulfates are 
aromatic (phenolic), and not aliphatic, as in GAGs (see Figure 2.1). Hence, sulfates in CS 
are relatively more labile due to the tendency of a phenolic sulfate to lose sulfonate and 
form phenolic-OH by resonance stabilization. This makes the characterization of CS 
without pre-column derivatization or inclusion of protecting additives, such as sheath gas 
etc. in the MS, an arduous task. 
In contrast to the aforementioned methods, RPIP-UPLC-MS allows for analysis 
of compounds without the necessity for pre- or post-column modifications. It is a highly-
sensitive method requiring very small amounts of sample and has been well reported in 
the analyses of highly sulfated structurally complex heparin and HS oligosaccharides.  
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Traditionally used ion-pairing agents are alkyl sulfates (negatively-charged ion-
pairing agents) for the retention of positively-charged analytes and tetraalkylammonium 
phosphates (positively-charged ion-pairing agents), in case of anionic analytes. In this 
study, we  used an array of primary (linear) and tertiary (branched) amines as ion-pairing 
agents and tested each of them in concentrations ranging 5 to 50 mM to find the optimal 
agent and optimal concentration for UPLC retention and MS identification of CS. 
2.2 Experimental methods 
2.2.1. Materials 
 (+) − catechin sulfate (CS) and (−) − epicatechin sulfate (ECS) (synthesized by 
the Desai lab and stored in -80°C), ion-pairing agents, i.e., n-butylamine (BTA), n-
pentylamine (PTA), n-hexylamine (HXA) of the highest purity were purchased from 
Fisher Scientific (Fair Lawn, NJ). Tripropylamine (TPA) and tripentylamine (TPentA) of 
the highest purity, and solvents such as optima LC-MS grade acetonitrile, methanol, were 
from Sigma (St. Louis, MO). Optima LC-MS grade formic acid was purchased from 
Fisher Scientific (Fair Lawn, NJ) and Nerl high-purity water from Thermo Fisher 
Scientific (Middletown, VA).  
2.2.2. RP-IP UPLC-MS of Catechin Sulfate  
Ultraperformance liquid chromatography (UPLC) was used in conjunction with 
electrospray ionization-mass spectrometry (ESI-MS) in order to characterize CS. Waters 
Acquity H-class UPLC system equipped with a triple quadrupole mass spectrometer 
(TQD-MS) was used to perform all experiments. 
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A reversed-phase Waters BEH (Ethylene Bridged Hybrid) C18 column of 1.7 µm 
particle size and 2.1 x 50 mm dimensions was used as the column for all the UPLC 
experiments. A flow rate of 500 μL/min and column temperature of 40°C was maintained 
during separation. Solvent A consisted of 5-50 mM ion-pairing agent in water containing 
0.1% v/v formic acid (to protonate ion-pairing agent) and solvent B consisted of 5-50 
mM ion-pairing agent in acetonitrile–water mixture (3:1 v/v) containing 0.1% (v/v) 
formic acid. 
CS and ECS synthesized in our lab were used (Figures 2.13 and 2.14 are 
corresponding NMR spectra) and 0.5 mM solutions were made by adding 70 µL of 10 
mg/ml of each in 1.5 ml water. 5 µL of this sample was injected onto the column. A 7 
minute run was performed at a gradient starting with 20% solvent B, rising linearly to 
80% in 3 minutes (20% per min). The flow was then set to isocratic for 2 minutes, 
followed by a return to initial conditions in the last 2 minutes. 
The eluent from the UPLC was directly introduced into the TQD-MS. MS 
experiments were performed in positive mode as it was found to be better than negative 
mode in previous studies with heparin oligosaccharides 95 and in our UPLC-MS 
experiments with CS (Figure 2.12) and other sulfated molecules in general. For MS 
tuning at positive mode, capillary voltage was set at 4 kV with a desolvation temperature 
of 350°C and gas flow at 650 L/hr. UPLC-MS method consisted of scans for m/z ranges 
of 200-2048 with scan time of 0.25 seconds. Selected Ion Recording (SIR) set at a dwell 
time of 0.025 seconds, was also performed for masses corresponding to singly charged 
[CS-ion pairing agent] molecular adduct ion; m/z = [799.97 - 5 (Na) + 6 IPA] 1+.  
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2.3 Results and Discussion 
2.3.1. RP-IP UPLC-MS Characterization of CS 
UPLC-MS of  500 μM solutions of CS and ECS, in the absence of any ion-pairing 
agents in the mobile phase, resulted in poorly retained single peak eluting soon after 
solvent peak (0.30 minutes), at 0.33-0.35 minutes on the chromatogram (see Figure 2.4).  
Therefore, retention factor (equation explained in chapter 1), 
 
 
The peaks in both cases showed a retention factor, kʹ ~ 0.1, which is much less 
than the ideal kʹ range of 5-20.  
The mass spectra of these CS and ECS peaks did not show the presence of 
molecular ion, [M + H] + ; m/z = 800.78, or sodiated adduct [M + Na] + ; m/z = 822.76. 
Instead, we observed signals that corresponded to m/z of protonated molecular ion devoid 
of a single sodium sulfonate group i.e. [(M – NaSO3) + H] +, m/z = 698.3 (ppm error ≤ 
0.5) at electron count intensities of 195290 (1.9e5) and 547273 (5.4e5) for ECS and CS 
respectively. Also found in greater abundance were peaks corresponding to loss of upto 
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four sulfate groups (see Figure 2.5). These peaks are hypothesized to arise out of 
structural modifications of analyte molecules in the (a) LC column, (b) MS source. 
As the LC run begins and mobile phases flow through the column, 0.5 μM formic 
acid in the mobile phases forms hydrophobic interactions with the stationary phase via its 
alkyl carbon. In a fashion similar to ion-exchange chromatography, sodium ions of CS 
and ECS injected into the column may be dynamically exchanged with the protons of 
ionized formic acid, modifying the molecule structure (CS or ECS) in the UPLC column 
(see Figure 2.2).  
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Figure 2.2 Dynamic ion exchange in the UPLC column results in atleast six inter-convertible 
forms of CS entering into the MS source 
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As six possible forms of CS/ECS enter into the MS source, it is observed that they 
fragment into smaller molecules due to lability of sulfate groups to high voltage potential 
and temperature conditions in the source (see Figure 2.3). The presence of metal cations 
such as sodium seems to do less to protect these groups from cleaving off the molecule 
scaffold. 
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Figure 2.3 Three fragment ions (highlighted in yellow) formed in the MS source, from different 
CS molecules in the column eluate  
 46 
Mass spectra shows the presence of these three fragment ions as well as many 
others, representing MS data of poor quality (see Figure 2.5). 
In the presence of 5 to 50 mM ion-pairing agents in the mobile phases, UPLC-MS 
of CS was performed, in both positive and negative MS modes. In both modes and in 
presence of all the ion-pairing agents used (see Figure 2.6), peak for CS molecular adduct 
ion, [(M – 5 Na + 5 IPA) + 1 IPA] 1+, was observed. Retention improved significantly as 
CS showed kʹ values ranging from 0.2 to 11 in the presence of linear and tertiary amines. 
Figure 2.7 represents a plot of kʹ versus concentration of ion pairing agents (mM) where 
highest retention is observed with tripentylamine and lowest in case of n-butylamine. 
Optimal retention was observed with linear amines, PTA and HXA as well as tertiary 
amine, TPA i.e. k′ was observed between 4 and 8.   Single ion chromatograms show the 
presence of well retained CS molecular adduct ion at peak intensities of 7.86e6 and 2.84e7 
in presence of hexylamine and pentylamine respectively (see Figures 2.8 and 2.10). 
Retention times were at 1.53 and 2.04 minutes respectively, resulting in kʹ values 
between 4.1 and 5.8. Corresponding MS spectra show the presence of only the molecular 
adduct ion peak and no fragment ions, in both cases. Molecular adduct ion peak 
intensities are high and found to be ranging between e6 and e7 (see Figures 2.9 and 2.11). 
Figure 2.12 shows the decrease in MS signal intensities of molecular adduct ions, 
in case of negative mode. Under MS negative mode, in the presence of four ion-pairing 
agents at 5 to 50 mM concentrations, molecular adduct ion peaks were observed at 
intensities less than 20 % of those obtained in positive mode MS. 
Linear vs. Branched amines 
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Linear amines have been previously reported to give better peak capacities than 
quaternary and tertiary amines, in the UPLC-MS of heparin oligosaccharides.95 In case of 
CS, linear amines showed about ten times higher MS signal intensities than tertiary 
amines (for singly charged molecular adduct ions); indicating that linear amines due to 
their single chain structure, have a greater tendency to form adduct ion droplets in the MS 
source. Tertiary amines, owing to their branched shape, may occupy too much space or 
may conglomerate together and cause repulsions, preventing the formation of fine 
droplets in the MS source, during aerosol formation and/or ionization. Also, the use of 
tertiary amines has showed gradual decrease in overall MS sensitivity, indicating ion 
suppression associated with their MS application. 
 On the other hand, tertiary amines gave higher retention factors than linear 
amines, which can be attributed to the number of alkyl chains i.e. enhanced retention in 
the column stationary phase (Figures 2.8 and 2.10), as well as increased chances of 
encountering and ion-pairing with analyte molecules by means of their alkyl chain 
branches. It could therefore be assumed that greater the number of branches, greater is the 
retention, but this will soon be proved otherwise in chapter 3, giving us an idea of the 
complexity of ion-pairing mechanisms that take place in the column. 
Positive mode MS of CS in presence of linear ion-pairing agent (IPA) gave 
molecular adduct ion signal of m/z = [(M + 5 IPA) + 1 IPA] 1+ and branched IPA usually 
gave molecular adduct ion signal of m/z = [(M + 5 IPA) + 2 IPA] 2+, indicative of the 
increased propensity of CS to form doubly-charged ions in presence of branched ion-
pairing agents. Therefore, we suggest that the type of ions formed could be a function of 
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physical property such as structure of ion-pairing agent, with linear amines favoring 
formation of singly-charged ions and branched amines favoring multiply-charged ions.  
In addition to positive mode, all the runs were performed in negative mode MS, 
which resulted in formation of ions of m/z = [(M + 5 IPA) – 1 IPA] 1- and [(M + 5 IPA) – 
2 IPA] 2- , when ion-paired with linear and branched amines respectively. The MS signal 
intensities, however, were observed to be reduced, indicating the decrease in ability to 
form negatively-charged ions. 
In order to reach optimal MS conditions, several parameters such as temperature 
and capillary voltage had to be adjusted; however, the most important was found to be 
cone voltage. As cone voltage was increased beyond 20 V, a significant number of ion 
signals cropped up in the MS spectrum, corresponding to in-source fragmentation losses 
of sulfonates (as sulfonate-ion pairing agent) from the molecular adduct ion. However, 
these losses were more controlled and the molecular adduct ion was found to be highly 
stable, relative to when no ion-pairing technique was employed.  
At MS cone voltage of 20 V, molecular adduct ion peaks were obtained at highest 
intensities without any sulfonate losses, applicable across the board for all ion-pairing 
agents. 
Ion-pairing with linear amines helped successfully retain CS on the column and 
appropriate tuning of MS conditions, specifically cone voltage, resulted in intense 
molecular adduct ion signals and complete elimination of sulfonate group losses, 
overcoming both the hurdles using a single technique (Figures 2.9 and 2.11). 25 mM was 
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found to be the optimal concentration for all ion-pairing agents and HXA at 25 mM was 
found to be the best agent for UPLC-MS characterization of CS. Positive mode was 
found to be better ionizing than negative mode in this study.  
This method is simple, convenient and eliminates the need for any kind of pre-
column derivatization technique like permethylation, or any post-column sheath 
liquid/gas addition. In comparison to other methods like NMR, this technique requires far 
less amount of sample (5 μL) and is highly sensitive. Capillary electrophoresis has so far 
shown limited use as a characterization tool for CS it does not give any identification data 
despite giving good resolution and pairing CE with MS, as mentioned previously, is a 
procedure fraught with technical difficulties. 
In this work, we used RPIP-UPLC-MS, to successfully characterize CS, without 
the requirement of any kind of pre-column derivatization or post-column modifications. 
By utilizing ion-pairing agents, we were able to obtain good retention factors for CS and 
also observed that these agents imparted stability to sulfate groups of CS molecular 
adduct ion. MS cone voltage, when set at 20 V, was found to be optimum for less 
fragmentation and good signal intensity. Fragmentation was observed when the same 
experiment was conducted using cone voltages above 20 V. At voltages below 20 V, the 
molecules failed to ionize properly. 
After optimizing conditions such as type and concentration of ion-pairing agent, 
cone voltage etc. we obtained mass/charge information of intact CS, with little or no 
compromise to its structural integrity. This is the first report on UPLC-MS 
characterization of pentasulfated catechin sulfate. 
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Figure 2.4. Chromatograms for [M – 1 NaSO3 + 1 H] + ion of ECS (above) and CS (below), 
observed m/z =  698.3; Solvent A, water + 0.1%  v/v formic acid; Solvent B, acetonitrile + 0.1% 
v/v formic acid; cone voltage, 27 V. 
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Figure 2.5. Corresponding spectra for [M – 1 NaSO3 + 1 H] + ion of ECS (above) and CS 
(below), observed m/z = 698.3;  Solvent A, water + 0.1% v/v formic acid; Solvent B, acetonitrile 
+ 0.1% v/v formic acid; cone voltage,  27 V. 
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Figure 2.7. Plot showing CS retention factor vs. ion-pairing agents at concentrations ranging 
from 5 to 50 mM  
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Figure 2.8. Chromatogram for [M + 1 HXA] + ion of CS, observed m/z = 1298.4;  Solvent A, 25 
mM HXA in water + 0.1% v/v formic acid; Solvent B, 25 mM HXA in acetonitrile: water (3:1) + 
0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 2.9. Mass spectrum for [M + 1 HXA] + ion of CS, observed m/z = 1298.4;  Solvent A, 25 
mM HXA in water + 0.1% v/v formic acid; Solvent B, 25 mM HXA in acetonitrile: water (3:1) + 
0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 2.10. Chromatogram for [M + 1 PTA] + ion of CS, observed m/z = 1213.4;  Solvent A, 25 
mM PTA in water + 0.1% v/v formic acid; Solvent B, 25 mM PTA in acetonitrile: water (3:1) + 
0.1% v/v formic acid; cone voltage, - 20 V. 
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Figure 2.11. Corresponding mass spectrum (below) for [M + 1 PTA] + ion of CS, observed m/z= 
1213.4;  Solvent A, 25 mM PTA in water + 0.1% v/v formic acid; Solvent B, 25 mM PTA in 
acetonitrile: water (3:1) + 0.1% v/v formic acid; cone voltage, - 20 V. 
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Figure 2.12.  Signal intensities of CS molecular adduct ions in the presence of different ion-
pairing agent concentrations (5 to 50 mM), at both positive and negative MS modes. Negative 
mode shows consistently low intense signals (in case of all ion-pairing agents), relative to 
positive mode MS. 
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Figure 2.13. 1H NMR of CS 
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Figure 2.14. 13C NMR of CS 
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CHAPTER 3  
Development of Reversed-Phase Ion-Pairing Liquid Chromatography-Mass 
Spectrometric Analysis Of Small Molecule Heparin Mimetics of Various Scaffolds 
The Desai lab has been investigating and synthesizing sulfated small molecules of 
different scaffolds such as tetrahydroisoquinolines, isoquinazolinones, benzofurans, 
flavanoids etc., aiming to discover a suitable scaffold and the optimal number of sulfates 
required to exhibit heparin mimicking actions. Factor Xa is a serine protease which plays 
an important role in the coagulation cascade by activating prothrombin to thrombin. 
Thrombin, thus formed, binds to soluble fibrinogen and activates it into insoluble fibrin. 
Fibrin, along with Factor XIIIa, is what forms a “clot”. A few of the sulfated 
tetrahydroisoquinolines generated by our lab have shown potent factor Xa 
inhibition,114,115 while some sulfated quinazolinones have been reported to inhibit 
angiogenesis.116 Most recently, our monosulfated benzofuran dimers were found to be 
selective allosteric thrombin modulators.117,118 These small molecules are of low 
molecular weight, homogenous and hence, like CS, are predicted to have more specific 
effects than that of polymeric GAGs, such as heparin and HS. 
Since these molecules have demonstrated impressive biological activities, it 
becomes imperative to develop analytical techniques for use in biological fluids. The ion-
pairing UPLC-MS method employed for the characterization of CS was hypothesized to 
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be useful for these molecules (Figure 3.1) also. Thus, MS conditions were screened to 
identify optimal method for characterizing a structurally diverse group of GAG mimetics.  
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Figure 3.1 Structures of sulfated small molecules designed by the Desai lab to mimic 
heparin; tetrasulfated tetrahydroisoquinolines, 1 and 2; pentasulfate flavanoid, 3; 
disulfated quinazoline, 4; monosulfated benzofuran dimer, 5. 
3.2 Experimental methods 
3.2.1. Materials 
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Molecules 1, 2, 3, 4 and 5 (synthesized by the Desai lab and stored in -80°C), Ion-
pairing agents i.e. n-butylamine (BTA), n-pentylamine (PTA), n-hexylamine (HXA) of 
the highest purity were purchased from Fisher Scientific (Fair Lawn, NJ). n-octylamine 
(OTA), n-nonylamine (NNA), Tripropylamine (TPA) and Tripentylamine (TPentA) of 
the highest purity and solvents such as optima LC-MS grade acetonitrile, methanol were 
from Sigma (St. Louis, MO). Optima LC-MS grade formic acid was purchased from 
Fisher Scientific (Fair Lawn, NJ) and Nerl High-purity water from Thermo Fisher 
Scientific (Middletown, VA).  
3.2.2. RP-IP UPLC-MS equipment and experimental conditions  
All RP-IP UPLC-MS conditions used are the same as that mentioned in section 
2.2.2., in chapter 2.  
3.3 Results and Discussion 
3.3.1. RP-IP UPLC-MS analysis of small molecules 1, 2, 3, 4 and 5 
In the absence of ion-pairing agent in the system, all compounds, except for 
benzofuran dimer (molecule 5) were retained on the column for only 0.25 to 0.45 
minutes, kʹ < 2 (chapter two; Figure 2.4, chapter three; Figures 3.2, 3.4, 3.6, 3.8). In 
addition, their positive mode mass spectra were found noisy with several ion peaks; 
indicating extensive fragmentation of molecular ion or Na+ adduct ion (chapter two; 
Figure 2.5, chapter three; Figures 3.3, 3.5, 3.7, 3.9). As an exception, molecule 5 was 
retained fairly well, due to hydrophobicity of the scaffold and presence of only one 
hydrophilic sulfate group (see Figure 3.8). 
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Molecule 3, catechin sulfate, is discussed in chapter two, where ion-pairing with 
25 mM HXA was found to optimal for UPLC column retention and MS ionization of CS 
molecular adduct ion. Using the same MS conditions and LC gradient, ion-pairing was 
tested for molecules 1, 2, 4 and 5, each representing small molecule heparin mimetics of 
a scaffold. In order to study optimal IPA and IPA concentration for each scaffold, RP-IP 
UPLC-MS experiments were performed using linear amines; BTA, PTA, HXA, OTA, 
NNA and tertiary amines; TPA and TriPentA at concentrations 5 to 40 mM. All of these 
ion-pairing agents, at concentrations 5 to 40 mM, gave molecular adduct ion peaks for 
molecules 1 to 5; for example; using HXA as IPA, Figures 3.10, 3.12, 3.14, 3.16 show 
the total ion count chromatograms and single ion chromatograms for molecular adduct 
ions of 1, 2, 4, and 5 in the presence of 25 mM HXA. Figures 3.11, 3.13, 3.15, 3.17 are 
the corresponding spectra. 
Plotting k′ vs. concentrations of ion-pairing agents led us to conclude that 
molecular adduct ion peaks were observed at LC retention times and MS signal 
intensities dependent on IPA structure and concentrations. To elaborate, Figure 3.18 
shows kʹ values of molecule 1 plotted against increasing concentrations of linear amine 
ion pairing agents. Retention was observed to increase with increasing order of alkyl 
chain length of IPA. BTA (alkyl number, n = 4) retains molecule 1 the least, kʹ < 1; 
whereas NNA (alkyl number, n = 9) retains it the highest, kʹ > 14.  Also, within each 
IPA, retention factors increased as concentrations increased from 5 to 25 mM and 
proceeded to plateau or decrease from 25 to 40 mM. Similar plots (Figures 3.19 to 3.22) 
indicate a similar trend of linear amine IPA effect on retention of molecules 2 to 5.  
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On the other hand, tertiary amines, TPA and TPentA, also gave high kʹ values 
between 3 and 11 for molecules 1 to 5. TPentA showed greater retention than TPA for all 
molecules but at concentrations above 25 mM, was found to be immiscible with the 
aqueous mobile phase, hence kʹ values upto only 15 mM TPentA were obtained (Figures 
3.23 to 3.27). In case of TPA, plateau was not reached by 25 mM as retention factor 
values continued to increase at 40 mM, across the board for all molecules.  
In order to study the dependence of retention on the degree of sulfation of a 
molecule and to possibly be able to quantify the number of sulfates of an unknown 
molecule on basis of such a correlation, we plotted alkyl number/carbon atom number of 
ion-pairing agents tested versus kʹ values of molecules 1 to 5 at fixed concentrations; 15 
and 25 mM, of ion-pairing agents (Figures 3.28 and 3.29). Slope, m, for each molecule 
was calculated at both concentrations.  
For example, at 15 mM IPA, kʹ of pentasulfated CS (molecule 3) was 0.615 for 
BTA ( n = 4) and 17.1 for NNA ( n = 9). Therefore,  
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Similarly, slope values were calculated for molecules 1 to 5 and a correlation was 
established. 
Plotted in Figure 3.28, are the slopes of retention factors (k´) of molecules 1-5 at 15 mM 
ion-pairing agent concentration (carbon atom number 4 to 9). Slope values (m) show 
direct proportionality with number of sulfate groups on retained molecule. For e.g. 
molecules 1 and 2 have four sulfate groups each and have similar hydrophobic surface 
areas and their kʹ slope values are found to be 2.88 and 2.91 respectively. Molecule 5, 
with the lowest number of sulfates (n= 1), shows the smallest slope value of 1.415, 
whereas CS (molecule 3) containing five sulfates shows the greatest slope value of 3.311. 
Figure 3.29 provides further evidence to our hypothesis by showing similar results at 25 
mM IPA concentration. 
Comparison of linear and tertiary amines of the same alkyl number was done by 
plotting kʹ values of analyte against increasing concentrations of ion pairing agents such 
as NNA and TPA where n = 9. The resultant plot (Figure 3.30) shows higher k´ values in 
case of linear amine at concentrations 5 mM to 25 mM. At 25 mM, NNA and TPA 
retained molecule 2 at kʹ ≈ 15 and kʹ ≈ 4 respectively.  
 
Ion-pairing with linear amines 
All the linear amines of increasing chain lengths; number of carbons/alkyl number 
= 4 to 9 (BTA, PTA, HXA, OTA, NNA), successfully ion-paired with compounds 1, 2, 4 
and 5. Molecular adduct ion was prominently seen in all spectra, with retention factors 
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increasing with IPA concentration, till 25 mM. Beyond 25 mM, the retention of all 
compounds remained the same, indicating saturation of column. 
BTA showed least retention of all molecules, while NNA showed greatest 
retention (Figures 3.18 to 3.22), indicating direct dependence of retention factor on alkyl 
chain length/carbon atom number of ion-pairing agent. Interestingly, the difference 
between the retaining effect of n and (n + 1) alkyl group containing ion-pairing agents 
like PTA and HXA was pronounced in compounds with higher number of sulfates. For 
e.g. at any concentration of ion-pairing agent, it can observed that difference in kʹ 
between any two consecutive ion-pairing agents is greatest in pentasulfated compound 3 
(Figure 3.20), followed by tetrasulfated 1 and 2, disulfated 4,  and lastly compound 5, 
monosulfated benzofuran showed least difference in retaining effect of ion-pairing agents 
(Figures 3.18, 3.19, 3.21, 3.22). These results show that ion-pairing is a phenomenon also 
dependent on analyte charge density. Hence, the selection of an optimum ion-pairing 
agent is incumbent upon the degree of sulfation of the target analyte. Analytes of lesser 
charge density would retain optimally with shorter chain length ion-pairing agents. 
Ion- pairing with tertiary amines 
In case of tertiary amines, similar to linear amines, the retention was found to be 
dependent on charge density of the sulfated molecule under study (Figures 3.23 to 3.27).  
Although it was observed that tertiary amines led to higher kʹ values than linear 
amines, when linear and tertiary amines of equal carbon atom number were compared, 
for e.g. TPA and NNA ( carbon atom number = 9), it was observed that NNA gave about  
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four times greater retention (Figure 3.30). This phenomenon indicates that ion-pairing in 
the column is strongly dependent on ion-pairing agent properties such as structure, 
greater than on the alkyl nature/carbon atom number of ion-pairing agent. 
Overall, it can be concluded that the retention of these sulfated small molecules, 
in presence of different ion-pairing agents, does not follow any particular pattern based 
on analyte properties such as analyte hydrophobicity, number of charges etc. However, 
the relative effect of different ion-pairing agents on the molecules seems to be directly 
dependent on number of charges carried by the molecule i.e. an analyte with higher 
number of sulfates showed greater increases in retention factor, kʹ, with increase in 
carbon atom number of ion-pairing agent.  
Not surprisingly, plots of retention factors of all compounds in the presence of 15 
and 25 mM ion-pairing agent vs. ion-pairing agents in increasing order of carbon atom 
number, gave slopes that correlate with degree of sulfation i.e. higher sulfated 
compounds such as 1, 2 and 3 gave slope values greater than those of lower sulfated 
compounds 4 and 5 (Figures 3.28 and 3.29).  
Further studies on a larger library of molecules are predicted to show if slope 
values could indeed be directly proportional to degree of sulfation and if so, then the next 
step would be to determine if the number of sulfates of the test compound could be 
predicted by its retention factor slope values or slope ranges. 
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In terms of ion-pairing agent properties that affect retention, dependence of kʹ on 
structure/shape seemed to be more pronounced than on number of carbon 
atoms/hydrophobicity.  
25 mM HXA was found to give intense distinct molecular adduct ion peaks with 
no sulfonate losses (Figures 3.11, 3,13, 3,15 and 3.17), at optimum retention factor values 
for all compounds (kʹ values between 6 and 12), closely followed by 25 mM PTA 
(Figures 3.18 to 3.22). 
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Figure 3.2. Sulfated small molecule 1; full scan (200-1000 amu) (above) and  single ion  
chromatogram (below) for [M + 1 H] + ion, m/z = 710.0; Solvent A, water + 0.1% v/v 
formic acid; Solvent B, acetonitrile + 0.1 % v/v formic acid; cone voltage, 20 V. 
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Figure 3.3. Corresponding mass spectrum of 1 at 0.27 min; [M + 1 H] + molecular ion peak of 
observed m/z = 710.0;  Solvent A, water + 0.1 % v/v formic acid; Solvent B, acetonitrile + 0.1% 
v/v formic acid; cone voltage, 20 V. 
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Figure 3.4. Sulfated small molecule 2; full scan (200-1000 amu) (above) and  single ion  
chromatogram (below) for [M + 1 H] + ion of observed m/z = 724.0; Solvent A, water + 0.1% v/v 
formic acid; Solvent B, acetonitrile + 0.1 % v/v formic acid; cone voltage, 20 V. 
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Figure 3.5. Corresponding mass spectrum at 0.26 min; [M + 1 H] + molecular ion peak of 
observed m/z = 724.0 and [M + 1 Na] + molecular ion-sodium adduct peak of observed m/z = 
746.0 are highest abundant, followed by sodium sulfate loss peaks (m/z, 600.4; 497.6); Solvent A, 
water + 0.1% v/v formic acid; Solvent B, acetonitrile + 0.1 % v/v formic acid; cone voltage, 20 
V. 
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Figure 3.6. Sulfated small molecule 4; full scan (200 - 1000 amu) (above) and  single ion  
chromatogram (below) for [M + 1 Na] + ion of observed m/z = 481.7; Solvent A, water + 0.1 % 
v/v formic acid; Solvent B, acetonitrile + 0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 3.7. Corresponding mass spectrum at 0.35 min; [M + 1 Na] + molecular ion-sodium 
adduct peak of observed m/z = 481.7 and [(M – 2 Na + 2 H) + 1 Na] +  base peak of observed m/z 
= 439.9;  Solvent A, water + 0.1 % v/v formic acid; Solvent B, acetonitrile + 0.1% v/v formic 
acid; cone voltage, 20 V. 
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Figure 3.8. Sulfated small molecule 5; full scan (200-1000 amu) (above) and  single ion  
chromatogram (below) for [(M – 1 Na + 1 H) + 1 H] + ion of observed m/z = 580.5; 
Solvent A, water + 0.1% v/v formic acid; Solvent B, acetonitrile + 0.1% v/v formic acid; 
cone voltage, 20 V. 
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Figure 3.9. Corresponding mass spectrum at 1.5 min; [(M – 1 Na + 1 H) + 1 H] + molecular ion 
peak of observed m/z = 580.5;  Solvent A, water + 0.1% v/v formic acid; Solvent B, acetonitrile + 
0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 3.10. Sulfated small molecule 1; full scan (200-1000 amu) (above) and  single ion  
chromatogram (below) for [(M – 4 Na + 4 HXA) + 1 HXA] + ion of observed m/z = 1128.07; 
Solvent A, water containing 25 mM HXA + 0.1% v/v formic acid; Solvent B, 3:1; water: 
acetonitrile containing 25 mM HXA + 0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 3.11. Corresponding mass spectrum at 1.88 min; [(M – 4 Na + 4 HXA) + 1 HXA] + 
molecular adduct ion peak of observed m/z = 1128.07; Solvent A, water containing 25 mM HXA 
+ 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1)  containing 25 mM HXA + 0.1% v/v 
formic acid; cone voltage, 20 V. 
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Figure 3.12. Sulfated small molecule 2; full scan (200-1000 amu) (above) and  single ion  
chromatogram (below) for [(M – 4 Na + 4 HXA) + 1 HXA] + ion of observed m/z = 1141.75; 
Solvent A, water containing 25 mM HXA + 0.1% v/v formic acid; Solvent B, acetonitrile: water 
(3:1)  containing 25 mM HXA + 0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 3.13. Corresponding mass spectrum at 1.88 min; [(M – 4 Na + 4 HXA) + 1 HXA] + 
molecular adduct ion peak of observed m/z = 1141.75; Solvent A, water containing 25 mM HXA 
+ 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1)  containing 25 mM HXA + 0.1% v/v 
formic acid; cone voltage, 20 V. 
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Figure 3.14. Sulfated small molecule 4; full scan (200-1000 amu) (above) and  single ion  
chromatogram (below) for [(M – 2 Na + 2 HXA) + 1 HXA] + ion of observed m/z = 718.0; 
Solvent A, water containing 25 mM HXA + 0.1% v/v formic acid; Solvent B, acetonitrile: water 
(3:1) containing 25 mM HXA + 0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 3.15. Corresponding mass spectrum at 1.94 min; [(M – 2 Na + 2 HXA) + 1 HXA] + 
molecular adduct ion peak of observed m/z = 718.00; Solvent A, water containing 25 mM HXA + 
0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1)  containing 25 mM HXA + 0.1% v/v 
formic acid; cone voltage, 20 V. 
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Figure 3.16. Sulfated small molecule 5; full scan (200-1000 amu) (above) and  single ion  
chromatogram (below) for [(M – 1 Na + 1 HXA) + 1 HXA] + ion of observed m/z = 781.0; 
Solvent A, water containing 25 mM HXA + 0.1% v/v formic acid; Solvent B, acetonitrile: water 
(3:1)  containing 25 mM HXA + 0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 3.17. Corresponding mass spectrum at 3.23 min; [(M – 1 Na + 1 HXA) + 1 HXA] + 
molecular adduct ion peak of observed m/z = 781.00; Solvent A, water containing 25 mM HXA + 
0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1)  containing 25 mM HXA + 0.1% v/v 
formic acid; cone voltage, 20 V. 
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Figure 3.18. Plot showing retention factor (kʹ) of molecule 1 (inset) in the presence of linear 
amines (ion-pairing agents) at concentrations ranging 5 to 40 mM. Solvent A, water containing 25 
mM ‘X’ + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM ‘X’ + 
0.1% v/v formic acid; cone voltage, 20 V. X = ion pairing agent. 
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Figure 3.19. Plot showing retention factor (kʹ) of molecule 2 (inset) in the presence of linear 
amines (ion-pairing agents) at concentrations ranging 5 to 40 mM. Solvent A, water containing 25 
mM ‘X’ + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM ‘X’ + 
0.1% v/v formic acid; cone voltage, 20 V. X = ion pairing agent. 
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Figure 3.20. Plot showing retention factor (kʹ) of molecule 3 (inset) in the presence of linear 
amines (ion-pairing agents) at concentrations ranging 5 to 40 mM. Solvent A, water containing 25 
mM ‘X’ + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM ‘X’ + 
0.1% v/v formic acid; cone voltage, 20 V. X = ion pairing agent. 
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Figure 3.21. Plot showing retention factor (kʹ) of molecule 4 (inset) in the presence of linear 
amines (ion-pairing agents) at concentrations ranging 5 to 40 mM. Solvent A, water containing 25 
mM ‘X’ + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM ‘X’ + 
0.1% v/v formic acid; cone voltage, 20 V. X = ion pairing agent. 
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Figure 3.22. Plot showing retention factor (kʹ) of molecule 5 (inset) in the presence of linear 
amines (ion-pairing agents) at concentrations ranging 5 to 40 mM. Solvent A, water containing 25 
mM ‘X’ + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM ‘X’ + 
0.1% v/v formic acid; cone voltage, 20 V.  X = ion pairing agent.  
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Figure 3.23. Plot showing retention factor (kʹ) of molecule 1 (inset) in the presence of tertiary 
amines (ion-pairing agents) at concentrations ranging 5 to 40 mM. Solvent A, water containing 25 
mM ‘X’ + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM ‘X’ + 
0.1% v/v formic acid; cone voltage, 20 V.  X = ion pairing agent, TPA or TPentA. 
 
 
 92 
 
Figure 3.24. Plot showing retention factor (kʹ) of molecule 2 (inset) in the presence of tertiary 
amines (ion-pairing agents) at concentrations ranging 5 to 40 mM. Solvent A, water containing 25 
mM ‘X’ + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM ‘X’ + 
0.1% v/v formic acid; cone voltage, 20 V.  X = ion pairing agent, TPA or TPentA. 
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Figure 3.25. Plot showing retention factor (kʹ) of molecule 3 (inset) in the presence of tertiary 
amines (ion-pairing agents) at concentrations ranging 5 to 40 mM. Solvent A, water containing 25 
mM ‘X’ + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM ‘X’ + 
0.1% v/v formic acid; cone voltage, 20 V.  X = ion pairing agent, TPA or TPentA. 
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Figure 3.26. Plot showing retention factor (kʹ) of molecule 4 (inset) in the presence of tertiary 
amines (ion-pairing agents) at concentrations ranging 5 to 40 mM. Solvent A, water containing 25 
mM ‘X’ + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM ‘X’ + 
0.1% v/v formic acid; cone voltage, 20 V.  X = ion pairing agent, TPA or TPentA. 
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Figure 3.27. Plot showing retention factor (kʹ) of molecule 5 (inset) in the presence of tertiary 
amines (ion-pairing agents) at concentrations ranging 5 to 40 mM. Solvent A, water containing 25 
mM ‘X’ + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM ‘X’ + 
0.1% v/v formic acid; cone voltage, 20 V.  X = ion pairing agent, TPA or TPentA. 
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Figure 3.28. Slopes of retention factors (k´) of molecules 1-5 at 15 mM ion-pairing agent 
concentration (carbon atom number 4 to 9), indicating linear relationship between kʹ and 
hydrophobicity of ion-pairing agent (irrespective of hydrophobic nature/surface area of retained 
molecule). Slope values (m), however, show direct proportionality with number of sulfate groups 
on retained molecule.  
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Figure 3.29. Slopes of retention factors (k´) of molecules 1-5 at 25 mM ion-pairing agent 
concentration (carbon atom number 4 to 9). Slope values (m) show the same properties as in case 
of 15 mM ion-pairing agent concentration. 
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Figure 3.30. k´ of molecule 2 in the presence of two ion-pairing agents of the same carbon atom 
number (C = 9) but different structures i.e. nonylamine, a primary amine and tripropylamine, a 
tertiary amine. 
Tripropylamine (TPA) 
Nonylamine (NNA) 
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3.3.2. RP-IP UPLC-MS Analysis of Sucrose Octasulfate (SOS) 
 Introduction 
Sucrose octasulfate is a small molecule comprising of a sucrose core scaffold, 
decorated with eight sulfate groups. Owing to its anionic nature, it has been observed to 
mimic interactions of cell-surface and free GAGs like chondroitin A and heparin with 
various ligands such as chemokine CCL complexes,119 fibroblast growth factor,120 
thrombin,121 etc. Recognizing that GAGs are structurally complex and challenging to 
synthesize, focus has been shifting towards use of small molecule inhibitors such as SOS 
in many therapies including anti-coagulation. SOS has also been found to show anti-viral 
properties by inhibiting interactions of viral amino acid residues with cell-surface 
GAGs.122 The aluminum salt of SOS is a commonly prescribed anti-ulcer agent 
(Sucralfate). In a study by Folkman et al., the binding of sucralfate to fibroblast growth 
factor (FGF) and its subsequent stabilization was reported.123 Subsequently, Volkin et al. 
reported that potassium salt of SOS also bound and stabilized FGF, triggering interest in 
investigating water-soluble SOS (sodium and potassium salts) as a potential heparin 
mimic.120 More recently, Sarilla et al. reported SOS as competing with heparin in binding 
to heparin cofactor II (HCII), an allosteric inactivator of thrombin.124 
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Figure 3.31. Sodium salt of sucrose octasulfate, exact mass = 1157.63 
The structural characterization of SOS, complete with its eight sulfates was first 
reported in its potassium heptahydrate salt form in 1992 by Silvey GL, using 1H and 13C 
NMR.125 This was followed by another study of SOS structure in solution, using 2D-
NMR. This report by Desai et al. compared solid state (by X-ray crystallography) and 
solution phase (nuclear Overhauser effect spectroscopy (NOESY)) SOS structural data.126 
The observed conformational differences were similar to those of sucrose octaacetate. 
Using X-ray crystallography, SOS was found to bind to thrombin with high affinity at 
exosite II, with a 1:1 (SOS:BT monomer) binding stoichiometry. Results from a 
spectrozyme TH hydrolysis assay showed higher affinity (lower Kd values) of SOS for 
thrombin than heparin and this was attributed to greater specificity of non-ionic 
interactions and solvent effects. Other spectroscopic methods, such as MS, have also 
been used to obtain a variety of data pertaining to interaction of SOS with proteins such 
as chemokines. Yu et al. used a filtration assay followed by ESI Fourier transform ion 
cyclotron resonance (ESI FT-ICR) MS to find that SOS bound to MCP-1 chemokine 
complex in 1:2 and 1:1 (MCP-1:SOS) stoichiometries and also calculated dissociation 
constants of these interactions using ESI FT- ICR MS and isothermal titration calorimetry 
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(ITC).119 This study aimed at establishing MS as a tool in studying protein-ligand 
interactions, specifically identifying inhibitors of chemokine-GAG interactions. 
The binding modes of SOS with proteins are also used as a model to understand 
heparin-protein binding. Yang et al. crystallized aprotinin with SOS to observe 5:1 
(aprotinin monomers:SOS) binding stoichiometry. Several conformations of SOS in the 
crystal provided an insight into the complex and variable binding of heparin with 
aprotinin.127 
Meanwhile, MS has also been pursued as an analytical tool for the 
characterization of SOS, and it was soon observed that SOS tended to lose some or all of 
its sulfates due to fragmentation in the MS source. Methods to overcome this hurdle and 
analyse SOS in its entirety have been developed and reported recently. In 2003, Gunay et 
al. published the first ESI-MS analysis of SOS using quaternary ammonium and 
phosphonium salts.128 They observed that direct infusion of SOS with 10mM 
tetraethylammonium hydroxide resulted in mass spectra that are devoid of sodium-SOS 
base peaks and contain less fragmentation. In 2006, Laremore et al. reported the use of 
ionic liquid matrices 1-methylimidazolium alpha-cyano-4-hydroxycinnamate and 
butylammonium 2,5-dihydroxybenzoate in the MALDI-TOF MS analysis of SOS and 
observed relatively less fragmentation.129 In a following report, they used bis-1,1,3,3-
tetramethylguanidinium alpha-cyano-4-hydroxycinnamate ionic liquid matrix to perform 
MALDI-TOF MS analysis of sodium, potassium and cesium salts of SOS, and found that 
the cesium and rubidium salts of SOS were least susceptible to MS fragmentation.130 The 
group successfully analyzed cesium salt of chondroitin sulfate A. In 2009, Ohara et al. 
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derivatized several types of saccharides including SOS using pyrenemethylguanidine and 
obtained MALDI-MS spectra of intact molecules at high signal intensities.131 In a recent 
study, Kinoshita et al. published the CE-UV analysis of sulfates after hydrolyzing them 
off sucrose octasulfate using HCl.132 This is a unique way of obtaining sulfate content of 
di- and oligo- saccharides. 
In this study, our aim was to eliminate the need for complex steps or reagents and 
use a simple one-step ion-pairing UPLC-MS method to successfully retain and analyze 
SOS with all the eight sulfates intact. This method also aims to separate and identify any 
impurities. From here on, SOS will refer to sodium salt of SOS only. 
3.3.2.1. Methods and experimental conditions 
3.3.2.2. Materials 
          Sucrose octasulfate was purchased from Biomol International (now Enzo Life 
Sciences International, Inc., Plymouth Meeting, PA) and stored in -80°C, n-pentylamine 
(PTA), of the highest purity was purchased from Fisher Scientific (Fair Lawn, NJ). 
Solvents such as optima LC-MS grade acetonitrile and methanol were from Sigma (St. 
Louis, MO). Optima LC-MS grade formic acid was purchased from Fisher Scientific 
(Fair Lawn, NJ) and Nerl High-purity water from Thermo Fisher Scientific (Middletown, 
VA).  
3.3.2.3. RP-IP UPLC-MS equipment and experimental conditions  
Refer to section 2.2.2., in chapter 2. 
 103 
3.3.2.4. Results and Discussion 
UPLC-MS of SOS in the absence of IPA resulted in molecular ion peak co eluting 
with solvent in 0.26 minutes, kʹ < 1 (Figure 3.32). The corresponding mass spectrum 
(Figure 3.33) shows the presence of SOS-Na+ adduct ion; [M + 1 Na+] +, m/z = 1180.5, at 
a peak intensity of 2.05 e6. However, one should note the significant amount of noise 
signals, also of e6 intensity range, generated from sulfate loss peaks. Peaks of m/z equal to 
1078.7, 976.9, 874.8, 772.8, 672.6 and 569.3 seen in Figure 3.33, represent SOS-Na+ ions 
formed after successive losses of one to six sodium sulfonates (NaSO3, mass = 102.95).  
In the presence of 25 mM PTA, SOS was easily retained and characterized using 
reversed-phase ion-pairing UPLC-MS. In Figure 3.34, single ion chromatogram for SOS 
molecular adduct ion, [SOS – 8 Na + 8 PTA) + 1 PTA] 1+ , m/z = 1768.7, a well retained 
sharp peak of 2.9 e7 signal intensity, is observed at 2.10 minutes, i.e. kʹ ≥ 7.  
Experiments were performed using same UPLC gradient and MS conditions 
discussed in previous chapters, except for cone voltage. Cone voltages ranging from 10 to 
100 V were tested for optimization of MS method (Figure 3.36).  
At 100 V, PTA adduct ion was observed, but at a very low intensity (m/z = 
1767.7; 5.5 e5). This was because of extensive break down of SOS at the MS source, 
especially sulfonate group losses. This is similar to the chromatogram obtained in the 
absence of ion-pairing agent, where sodium adduct ion can be identified amongst a 
cluster of other ion peaks which maybe noise and fragment ions, making it hard to 
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identify the peak of interest, as it elutes along with the solvent peak. This can make it 
impossible to interpret data if the analyte mass is unknown. 
At cone voltages between 50 to 100 V, peaks of m/z equal to 1600.5, 1432.4, and 
1264.3, corresponding to one, two and three sulfonate group-PTA complex losses 
respectively are observed. As we further reduce the cone voltage, fragmentation 
drastically lowers down i.e. at 20 and 10 V, only singly and doubly charged SOS-PTA 
ions peaks are present. 
Lowering the cone voltage to 20 V in the ion-pairing method for SOS resulted in 
a clean spectrum with no fragmentation (see Figure 3.35). The molecular adduct ion was 
obtained as a PTA adduct peak of m/z = 1768.7 (at 1.6 e7) but the base peak, however, 
was the doubly charged adduct ion, [(SOS – 8 Na + 8 PTA) + 2 PTA] 2+, m/z = 928.5 (at 
4.0 e7). An additional peak, m/z = 1208.4, was observed in the spectrum along with the 
singly and doubly charged molecular adduct ion peaks. This peak could be triply charged 
SOS trimer, after loss of six sulfates, [(3 SOS – 20 Na+ + 20 PTA – 6 PTA-SO3 + 6 H+) + 
3 PTA] 3+, m/z = (3625.86)/3 = 1208.62 (ppm error ≤ 0.2).  
At 10 V, there was no fragmentation but the intensities of the peaks were half that 
at 20 V i.e. singly charged molecular adduct ion, 1768.2 at 8.1 e6 and doubly charged 
molecular adduct ion, 928.2 at 2.6 e7 intensities. Hence 20 V was chosen as the optimal 
cone voltage for RP-IP UPLC-MS characterization of sodium salt of sucrose octasulfate. 
On basis of results from the RP-IP UPLC-MS analysis of molecules 1 to 5, 25 mM HXA 
is also expected to be a suitable ion-pairing agent for the analysis of SOS, possibly 
retaining SOS better than PTA, on the column. 
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Figure 3.32. SIR chromatogram for SOS sodium adduct ion in the absence of ion-pairing agents, 
mass = 1180.6, Solvent A, water + 0.1% v/v formic acid; Solvent B, acetonitrile + 0.1% v/v 
formic acid; cone voltage, 100 V. No retention observed as SOS elutes with the solvent peak at 
0.26 minutes. 
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Figure 3.33. Corresponding mass spectrum at 0.26 minutes. Spectrum shows SOS sodium adduct 
ion peak, m/z = 1180.5 as well as several extraneous peaks corresponding to ions resulting from 
sulfate losses due to fragmentation. Solvent A, water + 0.1% v/v formic acid; Solvent B, 
acetonitrile + 0.1% v/v formic acid; cone voltage, 100 V. 
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Figure 3.34. SIR chromatogram for SOS-PTA adduct ion, m/z = 1768.7, Solvent A, water 
containing 25 mM PTA + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 
mM PTA + 0.1% v/v formic acid; cone voltage, 20 V.  The single peak at 2.10 minutes has two 
other closely eluting peaks which seem to be stereoisomeric peaks since all 3 peaks gave the same 
mass spectra. 
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Figure 3.35. Mass spectrum for above chromatogram at 2.10 minutes. Spectrum shows SOS-PTA 
adduct ion peak, m/z = 1768.7 as well as doubly charged SOS-PTA ion peak, m/z = 928.5. 
Solvent A, water containing 25 mM PTA + 0.1% v/v formic acid; Solvent B, acetonitrile: water 
(3:1) containing 25 mM PTA + 0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 3.36.. Ion pairing with 25 mM PTA. Mass spectra for SOS-PTA adduct ion at different 
cone voltages. From top: 100 V; 50 V; 40 V; 20 V; 10 V. Solvent A, water containing 25 mM 
PTA + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM PTA + 0.1% 
v/v formic acid. 
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3.3.3. RP-IP UPLC-MS analysis of flavanoid dimers 6 and 7 
In order to test our ion-pairing reversed-phase UPLC-MS method on higher molecular 
weight molecules (MW > 1000), two flavanoid dimer molecules sulfated in our lab were 
used, which for sake of convenience will be referred to as 6 and 7. The method used for 
the molecules described in the previous chapters was followed and since HXA proved to 
be better retaining agent than PTA, 25 mM HXA was chosen as the ion-pairing agent for 
the following experiments. 
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Figure 3.37. Flavanoid dimers 6 and 7 (clockwise from left), m/z = 1461.64 and 1257.76 
respectively 
 
3.3.3.1. Methods and experimental conditions 
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3.3.3.2. Materials 
          Molecules 6 and 7 (synthesized by the Desai lab and stored in -80°C), n-
hexylamine (HXA) of the highest purity was purchased from Fisher Scientific (Fair 
Lawn, NJ).  
3.3.3.3. RP-IP UPLC-MS equipment and experimental conditions  
          Ultraperformance liquid chromatography (UPLC) was used in conjunction with 
UV spectrophotometry and electrospray ionization-mass spectrometry (ESI-MS) in order 
to retain and identify CS. Waters Acquity H-class UPLC system equipped with Acquity 
photodiode array detector and triple quadrupole mass spectrometer (TQD-MS) was used 
to perform all experiments. 
The eluent from the UPLC was directly introduced into the UV 
spectrophotometer, followed by the TQD-MS. UV wavelength was set at 190–400 nm 
range, with a resolution of 1.2 nm and the sampling rate was set at 20 points per second. 
All mass spectrometry was carried out in positive mode and for MS tuning, capillary 
voltage was set at 4 kV, cone voltage at 20 V, desolvation temperature at 350°C and gas 
flow at 650 L/hr. UPLC-MS method consisted of scans for m/z ranges of 200-2048 with 
scan time of 0.25 seconds. Selected Ion Recording (SIR) with a dwell time of 0.025 
seconds was also performed for masses corresponding to singly charged ‘compound-ion 
pairing agent’ molecular adduct ion; m/z = [M – x Na + (x + 1) HXA] 1+, where ‘x’= 
number of sulfates.   
3.3.3.4. Results and Discussion 
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Similar to all previously described small molecules, both 6 and 7 show early 
elution times  i.e., at 0.30 minutes after the solvent peaks (0.22 minutes) under normal 
UPLC-MS conditions (Figure 3.38) hence, kʹ ≤ 0.4. Despite the advanced UPLC system 
and high pressures, these highly water-soluble compounds are not retained by any 
significant degree. Also, in the MS, due to the thermolabile nature of sulfonate groups, 
they break down into smaller fragments by losing their sulfonates and also undergo inter 
and intra-ring cleavages (Figure 3.39), resulting in a mass spectrum containing too many 
peaks, with no useful information. 
To characterize 6 and 7, 25 mM HXA was used as the ion-pairing agent, since 
these molecules are larger and a longer chain ion-pairing agent ensures greater retention 
than a shorter chain IPA of the same concentration. Figures 3.40 to 3.43 show that 
molecules 6 and 7, which under normal conditions eluted at 0.3 minutes, were retained 
till 2.68 and 2.59 minutes respectively, in the presence of 25 mM HXA, whilst no 
changes in gradient conditions. Solvent peaks are observed at 0.21 and 0.27 minutes 
during RPIP UPLC-MS of 6 and 7, respectively, hence kʹ of 6 = 11.7 and kʹ of 7 = 8.59.  
Peaks eluting early at 2.48 and 2.56 minutes on the UV chromatogram of 6 (Figure 3.40), 
represent partially sulfated impurities resulting from incomplete synthesis and/ or 
degradation over time of storage. As these impurities are less hydrophilic, they ion-pair 
with fewer HXA ions, hence, elute slightly earlier than the fully sulfated molecule. 
Separation of these peaks depends on a number of factors, such as; gradient, strength of 
organic mobile phase, structure and alkyl chain length of IPA etc.  
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Mass spectra (Figures 3.41 and 3.43) show the presence of molecular ions as 
doubly charged HXA adduct ions. Molecular- HXA adduct ion of 6; [(M – 8 Na + 8 
HXA) + 2 HXA] 2+, m/z = 1149.94 (ppm error < 0.5) is observed at an intensity of 2.7 e6.  
Similarly, for 7; [(M – 8 Na + 8 HXA) + 1 HXA] 1+, m/z = 1834.55 (ppm error < 0.2), 
recorded at an intensity of 5.0 e6. Also seen in the spectrum is doubly charged molecular 
adduct ion, [(M – 6 Na + 6 HXA) + 2 HXA] 2+, m/z = 968.92 (ppm error < 0.5). 
Confirmation of charge of a molecular adduct ion peak can be made by examining 
the consecutive sulfonate loss peak. For example, Figure 3.41 shows the presence of a 
low intense peak (1.3 e5) of m/z = 1652.5. This peak results from loss of a single 
sulfonate-HXA group from singly charged molecular adduct ion i.e. 1834.55 – (80 + 
102.19 + 1 H) = 1652.5 (ppm error ≤ 0.8). Addition of hydrogen balances out the 
negatively charged oxygen that is left behind after loss of sulfonate.  On the other hand, 
doubly charged molecular adduct ion peak; m/z = 968.92 loses its sulfonate-HXA, i.e. m/z 
= [1936.74 – (80 + 102.19 + 1H)]/2 = 878.64 (ppm error < 1). Thus, the mass difference 
between doubly charged molecular adduct ion and its single sulfonate loss ion, thus, is 
90.28 (968.92 – 878.64). This is approximately equal to mass of (sulfonate-HXA – 1 H)/2 
= 181.19/2 = 90.59. 
Therefore, charge of molecular ion-IPA peak obtained using our RPIP UPLC MS 
method can be determined by this simple formula; 
Charge,  n 
 = mass of (sulfonate-IPA – 1H) / (mass difference between two consecutive m/z peaks) 
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This simple calculation can help in identifying MS peaks by correlating sulfonate 
losses with molecular adduct ion charges.  
The above results show the successful use of our RPIP UPLC-MS method in the 
characterization of sulfated flavanoid dimers and determination of charge by using 
sulfonate loss information. In conclusion, this method has proven robust enough to be 
applied to a wide range of compounds differing in scaffold type, molecular weights, 
hydrophobic surface areas and number of sulfates. 
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Figure 3.38. UV chromatogram (above) and mass chromatogram (below)  for molecule 6 in the 
absence of ion-pairing agents, Solvent A, water + 0.1% v/v formic acid; Solvent B, acetonitrile + 
0.1% v/v formic acid; cone voltage, 100 V. No retention observed as SOS elutes with the solvent 
peak at 0.26 minutes. 
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Figure 3.39. Corresponding mass spectrum of peak at 0.27 minutes, numerous peaks at noise 
level and resulting out of fragmentation, making it impossible to identify the molecular ion peak. 
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Figure 3.40. UV spectrum, total ion count mass chromatogram and single ion count 
chromatogram respectively (from top) of 6 in the presence of 25 mM HXA. UV peaks at 2.49 and 
2.56 minutes indicate degradation products (devoid of some sulfates) of 6. Solvent A, water 
containing 25 mM HXA + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 
25 mM HXA + 0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 3.41. Mass spectrum of total ion count chromatogram of 6 at 2.7 minutes, containing base 
peak of m/z = 1149.9 which corresponds to doubly charged adduct ion [(M + 8 HXA) + 2 HXA] 
2+ . Solvent A, water containing 25 mM HXA + 0.1% v/v formic acid; Solvent B, acetonitrile: 
water (3:1) containing 25 mM HXA + 0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 3.42. UV spectrum, mass chromatogram and total ion count chromatogram respectively 
(from top) of 7 in the presence of 25 mM HXA. UV peaks at 2.70 and 2.81 minutes indicate 
degradation products (devoid of some sulfates) of 7. Solvent A, water containing 25 mM HXA + 
0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 25 mM HXA + 0.1% v/v 
formic acid; cone voltage, 20 V. 
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Figure 3.43. Mass spectrum of total ion count chromatogram of 7 at 2.6 minutes, containing base 
peak of m/z = 1834.5 which corresponds to singly charged adduct ion [(M + 6 HXA) + 2 HXA] 
1+. Solvent A, water containing 25 mM HXA + 0.1% v/v formic acid; Solvent B, acetonitrile: 
water (3:1) containing 25 mM HXA + 0.1% v/v formic acid; cone voltage, 20 V. 
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CHAPTER 4   
Mass Spectrometric Fingerprinting Of Sulfated Small Molecules 
 
In 1919, based on J. J. Thompson’s discovery of neon isotopes, his student, 
Francis William Aston, reported the construction of the first mass spectrograph,133 for 
which he received the Nobel Prize in chemistry in 1921. While mass spectrometry has 
ever since been used to obtain the mass of a molecule, the introduction of another stage 
of mass analysis, in 1968, helped further obtain detailed structural information by means 
of “collision-induced dissociation”.134 This came to be known as tandem MS or MS/MS. 
Fingerprints of analytes can be developed using tandem MS, which in a nutshell, can be 
explained as the fragmentation of ions (formed in the MS source) in a collision cell 
containing an inert gas like helium or argon, generating unique daughter ions that are 
subsequently detected by a second mass analyzer that is present after the collision cell. 
Tandem MS or MS/MS is a popular and versatile structural tool with applications ranging 
from analyzing the yeast proteome135 to fingerprinting different kinds of beer136! In 
addition to tandem MS, MS alone can also be used for fingerprinting purposes, making 
use of a phenomenon called “up-front collision-induced dissociation” (also called in-
source fragmentation). This method is convenient and does not require a second mass 
analyzer, thus also named ‘the poor man’s MS/MS.137  
When parameters such as MS capillary voltage and cone voltage are suitably 
controlled, two regions that favor fragmentation are found; one being the region between 
the capillary and the skimmer cone, and the second is between the skimmer cone and the 
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quadrupole (or the extraction cone, when it is present). Due to voltage differences, the 
ions in these regions accelerate and as a result begin to collide with each other and 
surrounding nitrogen gas to give fragment ions (Figure 4.1). This is known as up-front 
collision-induced dissociation (up-front CID). 
Up-front CID occurs during most analyses, especially when the MS conditions are 
too harsh for the analyte. Bond breaking may give a good number of peaks in the mass 
spectrum that may provide useful information or may also result in information loss. This 
phenomenon can be used to our advantage by controlling certain parameters. One such 
important parameter is the cone voltage or the skimmer cone voltage. By maintaining MS 
source conditions ambient for controlled up-front CID; we have been able to develop 
unique fingerprints for all of the compounds that we tested using RPIP-UPLC MS. 
 
Figure 4.1 Schematic of up-front CID, V, velocity; N, nozzle; S, skimmer cone; Q, 
quadrupole.137  
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 4.2 Experimental methods 
4.2.1. Materials 
Molecules 1 to 7 (synthesized by the Desai lab and stored in - 80°C), Ion-pairing 
agent, n-hexylamine (HXA) of the highest purity was purchased from Fisher Scientific 
(Fair Lawn, NJ).  
4.2.2. RP-IP UPLC-MS equipment and experimental conditions  
Refer to chapter 3, section 3.3.3.3. 
4.2.3 Results and Discussion 
In normal UPLC-MS conditions with no ion-pairing agents, sulfate groups of 
analytes are paired with sodium ions or protons and are observed to be lost easily and in a 
random fashion (Refer to chapters two and three).  
Ion-pairing chromatography of sulfated molecules in presence of 25mM HXA 
was performed and MS data was collected at cone voltages 20, 40 and 60 V. In case of 
CS, at 20 V, there was no sulfonate loss observed and its intact molecular adduct ion, M1; 
[(M – 5 Na + 5 HXA) + 1 HXA] 1+, m/z = 1297.59, was detected and recorded by the 
mass spectrometer (Figure 4.3).  When the cone voltage was increased to 40 V, the 
obtained mass spectrum showed prominent peaks, M1 and M2; [M1]1+ - (1 HXA+ - SO3- 
+1 H+), m/z = 1116.52, corresponding to the CS molecular adduct ion and CS with one 
sulfonate-HXA pair loss respectively. Similarly at 60 V, further fragmentation up to loss 
of four sulfonate groups was observed (Figure 4.3 ; Table 1). Similar losses were also 
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observed in case of RPIP UPLC-MS of molecules 1 to 7, when ion-paired with 25 mM 
HXA (Figures 4.4 to 4.9; Tables 2 to 7). Sulfonate losses in the presence of ion-pairing 
agent were observed to be systematic, following a reproducible pattern. By implementing 
this simple yet unique method, we were able to fingerprint our sulfated small molecules 
(Figures 4.3 to 4.9, Tables 1 to 7), and also obtain the number of minimum sulfate groups 
on the molecule by examining the number of sulfonate losses. A loss of four sulfonates, 
as seen in case of molecule 3 at 60 V (Figure 4.3), guarantees the presence of at least four 
sulfates in the molecule.  
In addition, reproducible sulfonate loss patterns at a particular cone voltage serve 
as an important mathematical tool in understanding complex chromatograms of larger 
molecules such as sulfated polymers. As we note from all the MS spectra (Figures 4.3 to 
4.9) in this chapter and the previous chapter, a sulfonate loss spectrum always shows sets 
of peaks differing by a definite m/z value. This value could correspond to m/z of a single 
sulfonate group (mass = 79.96) or (sulfonate group-IPA)/n; where n = charge carried by 
the ion. Thus, by calculating the difference between the m/z values of two consecutive 
MS peaks, one can determine the charge of an ion peak. 
With increments in cone voltage to 20 V to 60 V, we observed that sulfated 
molecules gradually lost their sulfate groups due to up-front CID and these losses with 
increasing cone voltages were found to be highly reproducible when ion-pairing 
chromatography was used as opposed to normal UPLC-MS where up-front CID was 
random and occurred at lower cone voltages. It can thus be understood that ion-pairing 
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agents such as HXA are sulfate-group protecting and break off the molecule, ion-paired 
with sulfonate groups, when cone voltage is increased. 
Further up-front CID studies on different aromatic and non-aromatic sulfated 
molecules by modifying different parameters such as cone and capillary voltage, may 
help identify the positions of sulfate groups on the core scaffold. This information can 
help sequence unknown sulfated GAGs of medical importance and perhaps, understand 
the way in which sulfate groups assist in the binding of GAGs to proteins.  
 
 
O-O3SO
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OSO3-
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OSO3-
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+H3N
+H3N
+H3N
+H3N  
Figure 4.2. Singly-charged CS (3) molecular adduct ion droplet, [(M – 5 Na + 5 HXA) + 1 HXA] 
1+ = 1297.59; formed in the MS source, in the presence of 25 mM HXA. The circled regions 
indicate labile sulfonate groups that break off the molecular adduct ion during up-front CID when 
MS parameters such as cone voltage are increased. 
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Figure 4.3. MS fingerprint of CS at cone voltages 20 V, 40 V and 60 V respectively (from top).  
Solvent A, water containing 25 mM HXA + 0.1% v/v formic acid; Solvent B, acetonitrile: water 
(3:1) containing 25 mM HXA + 0.1% v/v formic acid; MS capillary voltage, 4 kV; desolvation 
temperature, 350°C and gas flow, 650 L/hr. 
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Table 1. In-source CID losses demonstrated by CS, ion-paired with 25 mM HXA at cone 
voltages 30 V, 40 V and 60 V, capillary voltage; 4 kV, desolvation temperature; 350°C and gas 
flow ; 650 L/hr. 
 
Cone 
voltage 
(V) 
Peak m/z formula Calculated m/z Observed m/z 
20 M1 [(M – 5 Na + 5 HXA) + 1 HXA] 1+ 1297.59 1298.45 
 M1ʹ [(M – 5 Na + 5 HXA) + 2 HXA] 2+ 699.89 700.34 
40 
M1 [(M – 5 Na + 5 HXA) + 1 HXA] 1+ 1297.59 1297.17 
M2 [M1] 1+ – 1 HXA+ - SO3- + 1 H+ 1116.52 1116.43 
60 
M1 [(M – 5 Na + 5 HXA) + 1 HXA] 1+ 1297.59 1297.09 
M2 [M1] 1+ – 1 HXA+ - SO3- + 1 H+ 1116.52 1115.95 
M3 [M1] 1+ – 2 HXA+ - SO3- + 2 H+ 1015.40 1014.90 
M4 [M1] 1+ – 2 HXA+ - 2 SO3- + 2 H+ 935.44 934.81 
M5 [M1] 1+ – 3 HXA+ - 2 SO3- + 3 H+ 834.32 833.65 
M6 [M1] 1+ – 3 HXA+ - 3 SO3- + 3 H+ 754.36 753.77 
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Figure 4.4. MS fingerprint of 1 at cone voltages 20 V, 40 V and 60 V respectively (from top).  
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1, [(M – 4 Na + 4 HXA) + 1 HXA] 1+, m/z = 1127.53 
 
Table 2. In-source CID losses demonstrated by molecule 1, ion-paired with 25 mM HXA, at cone 
voltages  30 V, 40 V and 60 V, capillary voltage; 4 kV, desolvation temperature; 350°C and gas 
flow ; 650 L/hr. 
 
Cone 
voltage 
(V) 
Peak m/z formula Calculated m/z Observed m/z 
20 M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 1127.53 1128.07 
40 
M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 1127.53 1127.11 
M2 [M1] 1+ – 1 HXA+ - SO3- + 1 H+ 946.45 945.81 
60 
M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 1127.53 1127.91 
M2 [M1] 1+ – 1 HXA+ - SO3- + 1 H+ 946.45 945.97 
M3 [M1] 1+ – 2 HXA+ - SO3- + 2 H+ 845.33 --- 
M4 [M1] 1+ – 2 HXA+ - 2 SO3- + 2 H+ 765.38 764.97 
M5 [M1] 1+ – 3 HXA+ - 2 SO3- + 3 H+ 663.25 663.63 
M6 [M1] 1+ – 3 HXA+ - 3 SO3- + 3 H+ 584.30 583.78 
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Figure 4.5. MS fingerprint of 2 at cone voltages 20 V, 40 V and 60 V respectively (from top).  
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2, [(M – 4 Na + 4 HXA) + 1 HXA] 1+, m/z = 1141.55 
 
Table 3. In-source CID losses demonstrated by molecule 2, ion-paired with 25 mM HXA, at cone 
voltages  30 V, 40 V and 60 V, capillary voltage; 4 kV, desolvation temperature; 350°C and gas 
flow ; 650 L/hr. 
 
Cone 
voltage 
(V) 
Peak m/z formula Calculated m/z 
Observed 
m/z 
20 M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 1141.55 1141.75 
40 
M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 1141.55 1141.79 
M2 [M1] 1+ – 1 HXA+ - SO3- + 1 H+ 960.47 960.57 
60 
M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 1141.55 1141.79 
M2 [M1] 1+ – 1 HXA+ - SO3- + 1 H+ 960.47 959.85 
M3 [M1] 1+ – 2 HXA+ - SO3- + 2 H+ 859.35 --- 
M4 [M1] 1+ – 2 HXA+ - 2SO3- + 2 H+ 779.39 778.85 
M5 [M1] 1+ – 3 HXA+ - 2SO3- + 3 H+ 678.27 677.75 
M6 [M1] 1+ – 3 HXA+ - 3SO3- + 3 H+ 598.32 597.81 
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Figure 4.6. MS fingerprint of 4 at cone voltages 20 V, 40 V and 60 V respectively (from top).   
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4, [(M – 4 Na + 4 HXA) + 1 HXA] 1+, m/z = 718.35 
 
Table 4. In-source CID losses demonstrated by molecule 4, ion-paired with 25 mM HXA, at cone 
voltages 20 V, 40 V and 60 V, capillary voltage; 4 kV, desolvation temperature; 350°C and gas 
flow ; 650 L/hr. 
 
Cone 
voltage 
(V) 
Peak m/z formula Calculated m/z 
Observed 
m/z 
20 M1 [(M – 2 Na + 2 HXA) + 1 HXA] 1+ 718.35 718.00 
40 
M1 [(M – 2 Na + 2 HXA) + 1 HXA] 1+ 718.35 718.06 
M2 [M1] 1+ – 1 HXA+  + 1 H+ 617.23 616.83 
M3 [M1] 1+ – 1 HXA+ - 1 SO3- + 1 H+ 537.27 536.95 
M4 [M1] 1+ – 2 HXA+ - 1 SO3- + 2 H+ 435.15 435.75 
60 
M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 718.35 --- 
M2 [M1] 1+ – 1 HXA+ - SO3- + 1 H+ 617.23 616.95 
M3 [M1] 1+ – 2 HXA+ - SO3- + 2 H+ 537.27 536.79 
M4 [M1] 1+ – 2 HXA+ - 2 SO3- + 2 H+ 435.15 435.78 
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Figure 4.7. MS fingerprint of 5 at cone voltages 20 V, 40 V and 60 V respectively (from top).  
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5, [(M – 1 Na + 1 HXA) + 1 HXA] 1+, m/z = 781.36 
 
Table 5. In-source CID losses demonstrated by molecule 5, ion-paired with 25 mM HXA, at cone 
voltages 20 V, 40 V and 60 V, capillary voltage; 4 kV, desolvation temperature; 350°C and gas 
flow ; 650 L/hr. 
 
Cone 
voltage 
(V) 
Peak m/z formula Calculated 
m/z 
Observed 
m/z 
20 M1 [(M – 1 Na + 1 HXA) + 1 HXA] 1+ 781.36 781.00 
40 M1 [(M – 1 Na + 1 HXA) + 1 HXA] 1+ 781.36 780.97 
M2 [M1] 1+ – (1 HXA+  + 1 H+) 680.24 679.86 
M3 [M1] 1+ – 1 HXA+ - 1 SO3- + 1 H+ 600.28 600.06 
60 M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 781.36 780.94 
M2 [M1] 1+ – 1 HXA+  + 1 H+ 680.24 679.82 
M3 [M1] 1+ – 1 HXA+ - 1 SO3- + 2 H+ 600.28 599.90 
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Figure 4.8. MS fingerprint of 6 at cone voltages 20 V, 40 V and 60 V respectively (from top).  
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Figure 4.9. MS fingerprint of 7 at cone voltages 20 V, 40 V and 60 V respectively (from 
top).  
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6, [(M – 8 Na + 8 HXA) + 2 HXA] 2+, m/z = 1149.50 
O
OO
-O3SO
OSO3-
OSO3-
O
O
O
OH
HO
OSO3-
OSO3-
OSO3-
NH3+
NH3+
+H3N
+H3N
NH3+
+H3N
NH3+
 
7, [(M – 6 Na + 6 HXA) + 1 HXA] 1+, m/z = 1834.72 
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Table 6. In-source CID losses demonstrated by molecule 6, ion-paired with 25 mM HXA, at cone 
voltages 20 V, 40 V and 60 V, capillary voltage; 4 kV, desolvation temperature; 350°C and gas 
flow ; 650 L/hr. 
 
Cone 
voltage (V) Peak m/z formula 
Calculated 
m/z 
Observed 
m/z 
20 M1 [(M – 8 Na + 8 HXA) + 2 HXA] 2+ 1149.50 1149.51 
40 
M1 [(M – 8 Na + 8 HXA) + 2 HXA] 2+ 1149.50 1150.99 
M2 [M1] 2+ – 1 HXA+ - 1 SO3- + 1 H+ 1058.94 1058.50 
M3 [M1] 2+ – 2 HXA+ - 1 SO3- + 2 H+ 1008.37 1008.85 
M4 [M1] 2+ – 2 HXA+ - 2 SO3- + 2 H+ 968.37 968.71 
M5 [M1] 2+ – 3 HXA+ - 2 SO3- + 3 H+ 917.30 917.89 
M6 [M1] 2+ – 3 HXA+ - 3 SO3- + 3 H+ 877.80 877.94 
M7 [M1] 2+ – 4 HXA+ - 3 SO3- + 4 H+ 827.23 826.89 
60 
M1 [(M – 8 Na + 8 HXA) + 1 HXA] 1+ 1149.50 --- 
M2 [M1] 2+ – 1 HXA+ - 1 SO3- + 1 H+ 1058.94 --- 
M3 [M1] 2+ – 2 HXA+ - 1 SO3- + 2 H+ 1008.37 1009.00 
M4 [M1] 2+ – 2 HXA+ - 2 SO3- + 2 H+ 968.37 968.051 
M5 [M1] 2+ – 3 HXA+ - 2 SO3- + 3 H+ 917.30 918.31 
M6 [M1] 2+ – 3 HXA+ - 3 SO3- + 3 H+ 877.80 877.67 
M7 [M1] 2+ – 4 HXA+ - 3 SO3- + 4 H+ 827.23 826.69 
M8 [M1] 2+ – 5 HXA+ - 4 SO3- + 4 H+ 736.12 736.21 
 
 140 
 
Table 7. In-source CID losses demonstrated by molecule 7, ion-paired with 25 mM HXA, at cone 
voltages 20 V, 40 V and 60 V, capillary voltage; 4 kV, desolvation temperature; 350°C and gas 
flow ; 650 L/hr. 
 
Cone 
Voltage (V) 
Peak m/z formula Calculated 
m/z 
Observed 
m/z 
20 
M1 [(M – 6 Na + 6 HXA) + 1 HXA] 1+ 1834.72 1834.55 
M1ʹ [(M – 6 Na + 6 HXA) + 2 HXA] 2+ 968.43 968.92 
40 
 
 
M1 [(M – 6 Na + 6 HXA) + 1 HXA] 1+ 1834.72 1833.12 
M2 [M1] 1+ – 1 HXA+ - 1 SO3-  + 1 H+ 1653.59 1653.54 
M3 [M1] 1+ – 2 HXA+ - 2 SO3- + 2 H+ 1472.46 1471.53 
M4 [M1] 1+ – 3 HXA+ - 3 SO3- + 3 H+ 1291.33 1290.56 
M1´ [(M – 6 Na + 6 HXA) + 2 HXA] 2+ 968.43 968.88 
M2´ [M1] 2+ – 1 HXA+ - 1 SO3-  + 1 H+ 877.86 877.71 
M3´ [M1] 2+ – 2 HXA+ - 2 SO3-  + 2 H+ 787.29 786.77 
60 
 
M1 [(M – 6 Na + 6 HXA) + 1 HXA] 1+ 1834.72 1834.14 
M2 [M1] 1+ – 1 HXA+ - 1 SO3- + 2 H+ 1653.59 1653.65 
M3 [M1] 1+ – 2 HXA+ - 2 SO3- + 2 H+ 1472.46 1471.78 
M4 [M1] 1+ – 3 HXA+ - 3 SO3- + 3 H+ 1291.33 1290.49 
M5 [M1] 1+ – 4 HXA+ - 4 SO3- + 4 H+ 1110.20 1108.64 
M6 [M1] 1+ – 5 HXA+ - 5 SO3- + 5 H+ 929.07 927.36 
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4.3 Fingerprints of positional isomers 
So far our RP-IP UPLC-MS method proved to be successful in analysis and 
fingerprinting of sulfated small molecules of various scaffolds and degree of sulfation. 
Our next step aimed at identifying any differences in fragmentation patterns amongst 
small molecules of the same molecular weight, scaffold and degree of sulfation but 
different in positions of decorating sulfate groups i.e. positional isomers. In order to 
proceed with this study, hydroxyl derivatives of three flavonoid small molecules (Figure 
4.10) were purchased and sulfated in our lab. 
OHO
OH O
OH
OH
OHO
O
OH
OH
OHO
OH O
OH
OH
OH8 9
10
 
Figure 4.10. Clockwise from left: 3, 5, 7, 4ʹ - Tetrahydroxyflavone (8); 3, 7, 3ʹ, 4ʹ - 
Tetrahydroxyflavone (9); 5, 7, 3ʹ, 4ʹ - Tetrahydroxyflavone (10) 
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Synthesis: 
50 mg of polyphenol flavanoid was taken in a microwavable tube and to it were 
added 24 equivalents (6 eq. per –OH) of triethylamine sulfur trioxide complex 
(Et3N:SO3), 4 equivalents (1 eq. per –OH) of triethylamine (Et3N) and 1 ml of acetonitrile 
(MeCN). This mixture was sealed and microwaved for two hours at 100°C (CEM 
Discover synthesizer, Cary, NC). After microwaving, the mixture was allowed to cool 
before being tested for completion of sulfation by performing thin-layer chromatography 
(TLC). Silica plates were used as the stationary phase and solvent contained 30% 
methanol in dichloromethane (DCM). The mixture was divided into several pools which 
were spotted onto the TLC plate using a capillary, to examine the progress of the 
sulfation reaction. Rotary evaporator (Rotavap) was used to evaporate excess methanol 
and DCM. After evaporation, DCM was added in sufficient volumes, followed by three 
spoons of silica and the mixture was put back into the rotavap, till dry. Finally, 
purification step was carried out by performing flash chromatography, using gradient 
increase in % methanol/DCM mixture. Purified mixture was loaded onto an SP Sephadex 
C25 column to exchange TEA with sodium (Na). Fractions of the eluate were collected 
and lyophilized for 2 to 3 days, until powder was obtained. 
O
OH
HO
OH
O
OH
Et3N:SO3, Et3N
100°C, 2 hrs
microwave, MeCN
O
OSO3-
-O3SO
OSO3-
O
OSO3-
9s9  
Figure 4.11. Schematic of sulfation reaction; precursor, 9, is sulfated to persulfated product, 9s. 
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NMR structure elucidation: 
1H and 13C spectroscopy were used to characterize compounds 8s, 9s and 10s, 
dissolved in D2O and DMSO (see Figures 4.19 to 4.25). Experiments were performed 
using Bruker 400 MHz NMR spectrometer, reporting chemical shifts (in ppm).  
Sulfated compound 8 (8s). 1H-NMR (D2O, 400 MHz): 8.11 (m, 2 H), 7.46 (m, 2 H), 
7.12 (d, 1 H), 6.8 (d, 1 H), 1H-NMR (DMSO, 400 MHz): 12.36 (s, 1 H), 8.13 (m, 2H), 
7.21 (m, 2H), 6.91 (d, 1H), 6.54 (d, 1H),  13C-NMR (DMSO, 100 MHz): 178.01, 160.21, 
159.62, 156.57, 155.60, 133.22, 129.74, 124.42, 119.24, 106.11, 101.90, 97.52, 52.82. 
Sulfated compound 9 (9s). 1H-NMR (DMSO, 400 MHz): 8.19 (d, 1 H), 8.07 (m, 1 H), 
7.99 (d, 1 H), 7.65 (d, 1 H), 7.46 (m, 1 H), 7.23 (m, 1 H), 13C-NMR (DMSO, 100 MHz): 
173.22, 158.14, 155.55, 146.57, 142.90, 134.84, 125.99, 124.67, 120.21, 118.69, 117.72, 
106.69. 
Sulfated compound 10 (10s). 1H-NMR (DMSO, 400 MHz): 8.14 (m, 1 H), 7.64 (m, 2 
H), 7.32 (m, 1 H), 7.21 (m, 1 H), 6.49 (m, 1 H). 13C-NMR (DMSO, 100 MHz): 175.70, 
160.60, 157.36, 152.92, 147.13, 143.82, 123.99, 120.39, 119.78, 117.46, 110.85, 108.07, 
106.81, 101.69, 39.57.  
1H-NMR of compound 8s dissolved in DMSO shows a peak at 12.36 ppm, which 
is not observed when it is dissolved in D2O (Figures 4.19 and 4.20). This is indicative of 
the presence of one hydroxyl group that remains after sulfation. When dissolved in D2O, 
the hydroxyl gets exchanged with deuterium (of D2O) and hence does not appear on the 
NMR spectrum. This could be the –OH at C-5 as it tends to hydrogen bond with adjacent 
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ketone group, leading to the formation of a six-membered ring.138 Therefore, difficulties 
in sulfating this hydroxyl group causes for end product to contain (n-1) sulfated 
compound along with persulfated compound, where n = number of hydroxyl groups on 
the precursor.  
4.3.1    Materials and Methods 
4.3.2 RP-IP UPLC-MS equipment and experimental conditions  
Refer to section 3.3.3.3., chapter 3. 
4.3.3    Results and Discussion 
Similar to previously discussed sulfated molecules, 8s, 9s and 10s are poorly 
retained on the column under normal UPLC-MS conditions, due to hydrophilicity of 
acidic sulfate groups. Figure 4.12 shows the elution of 8s along with the solvent peak, at 
0.3 minutes and an MS spectrum devoid of peaks, except for those from the solvent 
(Figure 4.13). On the other hand, in the presence of 25 mM HXA, the structural isomers 
are well retained (Figure 4.14), eluting not before 2 minutes (kʹ ~ 6).  
RP-IP UPLC-MS at cone voltages 20, 40, and 60 V give unique and reproducible 
fragmentation patterns (Figures 4.15 to 4.17). Table 8 identifies all the peaks observed in 
the spectra, with their calculated and observed m/z values. The isomers lost their sulfate 
groups at increased cone voltages to give peaks of the same m/z, but these losses occurred 
at different intensities. i.e. some losses were more pronounced in one isomer and less in 
the other (Table 9). The reproducible pattern of these intensities is what forms the 
essence of this MS fingerprint. Results obtained from duplicate runs performed in the 
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same RPIP UPLC-MS conditions showed the difference between 8s, 9s and 10s in the 
intensities of adduct ions formed after sulfonate-HXA losses, relative to the molecular 
adduct ion (Figure 4.18). 
Differences in sulfonate loss intensities amongst the three positional isomers 
tested may be due to structural factors such as steric hindrances or even physical factors 
such as shape of the ion droplet formed and its stability in the MS ion source. It is 
interesting to note that these differences are present and reproducible only when ion-
pairing agents are used in their UPLC-MS characterization. As a result, the losses of 
sulfonate groups are unique for each isomer, hence, [M - SO3]: [M] ratios can be used to 
accurately identify unknown isomers. Collection of such MS fingerprint data for a large 
number of samples can be used to compile an MS library. 
Since our compounds have four sulfate groups each, it is hard to make any 
conclusions regarding which sulfonate(s) group is lost when looking at the spectrum but 
similar studies on mono and di-sulfated isomers can give us fundamental understanding 
of regions on the scaffold where a sulfate group is most vulnerable to MS loss. This 
information can lead us to understanding the number and positions of sulfate groups in 
HS GAGs and therefore unlock the key to their specific and non-specific binding 
affinities to proteins in our body. Analysis of sulfated molecules for purity, degradation 
or identification of isomeric forms using our RP-IP UPLC-MS method can give us 
knowledge of stable and unstable sulfate groups, helping design better heparin mimics. 
Further studies involving analysis of sulfated small molecules in plasma are predicted to 
help us understand their behavior in-vivo. 
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Figure 4.12. UV chromatogram and mass chromatogram respectively (from top), for molecule 8s 
in the absence of ion-pairing agents, Solvent A, water + 0.1% v/v formic acid; Solvent B, 
acetonitrile + 0.1% v/v formic acid; cone voltage, 20 V. No retention observed as 8s elutes with 
the solvent peak at 0.3 minutes. 
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Figure 4.13. Corresponding mass spectrum for molecule 8s in the absence of ion-pairing agents, 
Solvent A, water + 0.1% v/v formic acid; Solvent B, acetonitrile + 0.1% v/v formic acid; cone 
voltage, 20 V.  
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Figure 4.14. Chromatograms of 9s, 10s and 8s respectively (from top), in the presence of 25 mM 
HXA. Retention increased from 0.3 to 2.2 minutes; isomers show minute differences in elution 
times. Solvent A, water containing 25 mM HXA + 0.1% v/v formic acid; Solvent B, acetonitrile: 
water (3:1) containing 25 mM HXA + 0.1% v/v formic acid; MS capillary voltage, 4 kV; 
desolvation temperature, 350°C and gas flow, 650 L/hr. 
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Figure 4.15. MS fingerprint of molecule 8s at cone voltages 20 V (top), 40 V (middle) and 60 V 
(bottom).   
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Figure 4.16. MS fingerprint of molecule 9s at cone voltages 20 V (top), 40 V (middle) and 60 V 
(bottom).   
 151 
 
Figure 4.17. MS fingerprint of molecule 10s at cone voltages 20 V (top), 40 V (middle) and 60 V 
(bottom).   
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Table 8. Mass spectral data obtained by RPIP UPLC-MS of sulfated positional isomers, 8s; 9s; 
and 10s, in increasing order of cone voltage conditions 
 
C
on
e 
vo
lta
ge
 (V
) 
Pe
ak
 
m/z formula 
C
al
cu
la
te
d 
m
/z 
Observed m/z 
8s 9s 10s 
20 M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 1114.50 1113.07 1112.96 1113.03 
 M1a [M1] 1+ – 1 HXA+  + 1 H+ 1013.37 - 1011.69 1011.97 
 M2 [M1] 1+ – 1 HXA+ - SO3- + 1 H+ 933.37 932.43 931.65 932.32 
40 
M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 1114.50 1113.00 1113.00 1112.92 
M1a [M1] 1+ – 1 HXA+  + 1 H+ 1013.37 - 1011.77 1011.81 
M2 [M1] 1+ – 1 HXA+ - SO3- + 1 H+ 933.37 932.59 931.81 931.85 
 M2a [M2] 1+ – 2 HXA+  + 2 H+ 832.24 830.59 830.52 830.75 
 M3 [M2] 1+ – 2 HXA+ - 2 SO3- + 2 H+ 752.24 750.68 750.56 750.64 
 M3a [M3] 1+ – 3 HXA+  + 3 H+ 651.11 649.36 649.21 650.03 
60 
M1 [(M – 4 Na + 4 HXA) + 1 HXA] 1+ 1114.50 1112.88 - 1112.96 
M1a [M1] 1+ – 1 HXA+  + 1 H+ 1013.37 - 1011.73 1011.69 
M2 [M1] 1+ – 1 HXA+ - SO3- + 1 H+ 933.37 931.58 931.85 931.81 
M2a [M2] 1+ – 2 HXA+  + 2 H+ 832.24 830.63 830.59 830.59 
M3 [M2] 1+ – 2 HXA+ - 2 SO3- + 2 H+ 752.24 750.72 750.68 750.68 
M3a [M3] 1+ – 3 HXA+  + 3 H+ 651.11 649.40 649.48 649.48 
 M4 [M3] 1+ – 3 HXA+ - 3 SO3- + 3 H+ 571.11 569.43 569.43 569.47 
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Table 9. MS signal intensity-based fingerprint data of peaks M1, M2 and M3 of 8s, 9s and 10s, at 
cone voltage, 40 V. 
 
Peak (m/z) 
Average Peak Intensity (run 1, run 2) at 40 V 
8s 9s 10s 
M1 (1113.0) 4.7 e6 (4.3 e6; 5.0e6) 8.2 e6 (9.3 e6; 7.2 e6) 2.9 e6 (2.7 e6; 3.2 e6) 
M2 (932.5) 1.5 e6 (1.5 e6; 1.4 e6) 3.9 e6 (4.4 e6; 3.4e6) 2.6 e6 (2.5 e6; 2.7 e6) 
M3 (750.5) 5.7 e5 (5.2 e5; 6.2 e5) 2.2 e5 (2.4 e5; 1.9 e5) 3.6 e5 (3.5 e5; 3.7 e5) 
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Figure 4.18. Percentages of [M - 1 SO3-], M2; and [M - 2 SO3-], M3 ions, relative to molecular 
adduct ions (M) i.e. 8s, 9s and 10s (A through C). MS fingerprint; cone voltage, 40 V. Percentage 
losses were calculated as the average from 2 runs, standard deviation indicated by error bars. 
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Figure 4.19. 1H-NMR of 8s in D2O 
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Figure 4.20. 1H-NMR of 8s in DMSO 
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Figure 4.21. 13C-NMR of 8s in DMSO 
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Figure 4.22. 1H-NMR of 9s in DMSO 
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Figure 4.23. 13C-NMR of 9s in DMSO 
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Figure 4.24. 1H-NMR of 10s in DMSO 
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Figure 4.25. 13C-NMR of 10s in DMSO 
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CHAPTER 5  
RPIP UPLC-MS Of Sulfated Penta O-Galloyl D-Glucopyranose (SPGG) 
Biochemical screening of a focused library of sulfated, small molecules belonging 
to the flavonoid, tetrahydroisoquinoline, cinammic acid, and gallic acid series led to the 
identification of SPGG, an aromatic heparin mimetic, now known to possess eight to 
eleven sulfate groups. SPGG inhibited factor XIa with an IC50 of 626 nM, which was at 
least 200-fold better than that for factors IIa, Xa, IXa and XIIa. SPGG prolonged human 
plasma clotting time selectively in the activated partial thromboplastin assay and 
prevented whole blood clotting at concentrations as low as 26 μM. Michaelis–Menten 
kinetic studies performed by the Desai lab showed that SPGG induced a significant 
reduction in the VMAX without much affecting the apparent KM suggesting an allosteric 
mechanism of factor XIa inhibition. The presence of unfractionated heparin reduced the 
IC50 of SPGG, which matched the loss in potency predicted on the basis of ideal 
competition between the two allosteric ligands. No chemically synthesized molecule has 
been discovered so far that exhibits such high potency for FXIa inhibition coupled with 
an allosteric mechanism.18  
Aside from the parent PGG core and the presence of sulfate groups, the structure 
of SPGG was relatively unknown, prior to UPLC-MS analysis. The globular core 
structure of PGG makes it highly flexible and presumably difficult to sulfate all the 15 
hydroxyl groups attached. As a result, the end product of this partial sulfation is a mixture 
of variedly sulfated SPGG compounds (see schematic in Figure 5.1). In this chapter, we 
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discuss the characterization of this complex mixture using the RPIP UPLC-MS method 
that we successfully used for the compounds discussed in the previous chapters. Also, we 
use up-front CID, for the first time on an unknown mixture, to deduce important 
structural information pertaining to SPGG. This practical application provides as a 
validation of sorts for the versatility of our RPIP UPLC-MS method in characterization of 
simple small molecules to larger complex mixtures. 
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Pentagalloyl glucopyranoside (PGG) Sulfated Pentagalloyl glucopyranoside( SPGG)  
Figure 5.1. Schematic of sulfation of PGG to SPGG; R = -OH, -OSO3 
 
5.2 Experimental methods 
5.2.1. RP-IP UPLC-MS equipment and experimental conditions 
SPGG synthesized in our lab was used and a 500 μM solution was made by 
dissolving in water. 5 µL of this sample was injected onto the column. A 26 minute run 
was performed at a shallow gradient starting with 20% solvent B, rising linearly to 80% 
in 20 minutes (3% per min).  This was to ensure maximum column separation of closely 
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related SPGG components. All other conditions were maintained the same as mentioned 
in earlier chapters (Refer to chapter 3, section 3.3.3.3). 
5.3 Results and Discussion 
Structure Determination of Sulfated Pentagalloyl Glucopyranoside (SPGG).  
The capillary electrophoretic profile of SPGG in reverse polarity mode displayed 
a complex, ill-resolved pattern indicating the presence of partially sulfated components 
(not shown). To identify the proportion and structure of these components, we resorted to 
reversed-phase ion-pairing UPLC-MS. In this technique, the ion-pairing agent, n-
hexylamine, is introduced in the mobile phase so as to replace sodium cations present on 
each sulfate group and impart considerable hydrophobicity to the molecule. Resolution 
arises from the different hydrophobicities of the constituents that contain varying number 
of n-hexylamine groups.  
Under normal UPLC-MS conditions, SPGG, owing to its high hydrophilicity, 
elutes as a broad peak in 0.29 minutes (see Figure 5.2). Ion-pairing with 25 mM HXA 
under a shallow gradient resulted in a UPLC profile of SPGG that showed the presence of 
five major nearly baseline resolved peaks, labeled p1 through p6 in Figure 5.3, each of 
which is further composed of multiple peaks. 
The ESI-MS profile of each peak, observed between 1000 and 2048 m/z range, 
was found to contain a doubly charged molecular adduct ion with a general formula of 
[(PGG+x×SO3-HXA–x×H)+2×HXA]2+, where x is the number of sulfonate (SO3)-
hexylammonium (HXA) groups present in the molecule (see Figures 5.6 through 5.11). 
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For example, peaks p3, p4 and p5 displayed molecular adduct ions at 1388.43, 1478.99 
and 1569.60 m/z, respectively, corresponding to doubly charged SPGG species 
containing  9, 10 and 11 sulfate groups with 11, 12 and 13 hexylamines, respectively, as 
ion-pairs. A similar behavior was observed for peaks p1, p2 and p6, which corresponded 
to SPGG species with 7, 8 and 12 sulfate groups, respectively. In addition to the 
molecular adduct ions, each of these peaks also displayed several other ions that arose 
due to the loss of one or more hexylamine-paired sulfonate groups further confirming the 
identity of parent sulfated species (Figures 5.6 to 5.10). 
Each of these peaks (p1 through p6), is a complex peak comprising of minor 
peaks. To further identify the origin of multiple components observed in peaks p1 
through p6, we utilized selective ion recording (SIR)–MS. In this technique, the 
spectrometer is tuned to monitor a specific ion, e.g., 1478.99 m/z corresponding to [M+10 
SO3+12 hexylamines]2+ ion, resulting in the identification of all peaks that contain this 
ion. Figure 5.4 shows three SIR profiles of SPGG. Monitoring at 1388.43 m/z gave a SIR 
profile that essentially mimicked peak p3 of the UV chromatogram suggesting that each 
component present in p3 contained nine sulfate groups. Likewise, monitoring at 1478.99 
or 1569.90 m/z resulted in a profile equivalent to the chromatogram of p4 or p5, 
respectively. This was also found to be the case for peaks p1, p2 and p6 (see Figures 5.4 
and 5.5). Figure 5.11 shows the division of peak p4 into 4 major arms or minor peaks; a, 
b, c, d. 
Mass spectra of the minor peaks within a given complex peak were observed at 20 
and 60 V. Figure 5.12 shows mass spectra of minor peaks of peak p4 at cone voltage 
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equal to 20 V.At 20 V, spectrum of each minor peak shows a single ion signal of the 
same m/z, i.e., 1479, corresponding to the molecular adduct ion. At 60 V, each spectrum 
showed additional ion peaks, arising from controlled fragmentation of molecular adduct 
ion (see Figure 5.13). The mass difference between any peak and its consecutive peak, on 
all mass spectra, was approximately equal to 91. Using the formula (see below, detailed 
in Chapter 4) to calculate peak charge, we found that, indeed, these ions carry a charge of 
+2, which matched with the mass differences. 
According to Figure 5.13 (mass spectrum at CV 60), 
M1 – M2 = [(PGG + (x) SO3-HXA) + 2 HXA] 2+ - [(PGG + (x-1) SO3-HXA + x H) + 2 
HXA] 2+ 
     ≈ 91  
Where x = number of sulfonate-HXA groups 
And charge, 
  n = [mass of sulfonate-IPA – 1H] /  (M1 – M2) 
= 181.13 / 91 
≈ 2 
Therefore, n = 2. Using this method, we were able to deduce the identity and 
charge of the peaks p1 through p6 by looking at the pattern of losses on each spectra. 
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Additionally, we observed that just like positional isomers 8s, 9s and 10s, the 
minor peaks within each peak, showed unique sulfonate loss intensity patterns, 
confirming that they represent positional isomers, each with a reproducible mass spectral 
fingerprint. 
In conclusion, UPLC-MS analysis of three independently prepared batches 
suggested that SPGG is a mixture of septa- (p1), octa- (p2), nona- (p3), deca- (p4), 
undeca- (p5) and dodeca- (p6) sulfated species, which further contain species with an 
identical number of sulfate groups (see Figure 5.14). It is likely that major peaks are 
partially resolved into complex peaks because of sulfate positional isomerism. This 
enhances the structural diversity of SPGG. Peaks p1 through p6 are present in proportions 
of 0.06:0.17:0.21:0.45:0.11:0.03, respectively (Figures 5.4 and 5.5). Using these 
proportions and the associated molecular weights, the weight-average molecular weight 
of SPGG was calculated to be 2668 (hexylammonium ion form) or 2178 (Na+ form). 
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Figure 5.2. UV chromatogram of UPLC-MS of SPGG in the absence of ion-pairing agents. Two 
peaks are seen; solvent peak, at 0.21 minutes; and SPGG at 0.29 minutes. Solvent A, water 
containing 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) containing 0.1% v/v formic 
acid; cone voltage, 20 V, t = 26 minutes. 
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Figure 5.3. RPIP UPLC-UV spectrum of SPGG in the presence of 25 mM HXA; Solvent A, 
water containing 25 mM PTA + 0.1% v/v formic acid; Solvent B, acetonitrile: water (3:1) 
containing 25 mM PTA + 0.1% v/v formic acid; cone voltage, 20 V, t = 26 minutes. 
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Figure 5.4. SIR of peaks p3, p4 and p5 of SPGG. (A) shows UPLC resolution of SPGG into six 
peaks (p3 to p5), which arise from variable sulfation of PGG. (B) – (D) show SIR monitoring of 
SPGG at 1388, 1479 and 1569 m/z to identify the peaks corresponding to 9, 10 and 11 sulfated 
PGG species. SIR = selective ion recording; See text for detailed interpretation. 
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Figure 5.5. SIR of peaks p1, p2 and p6 of SPGG. (A) shows UPLC resolution of SPGG into six 
peaks (p1 to p6), which arise from variable sulfation of PGG. (B) – (D) show SIR monitoring of 
molecule 6 at 1207, 1296 and 1660 m/z to identify the peaks corresponding to 7, 8 and 12 sulfated 
PGG species. SIR = selective ion recording; See text for detailed interpretation. 
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Figure 5.6. ESI-MS spectrum of peak p6 at 13.096 min in the range 200 – 2048 amu using a scan 
time of 0.25 s. PGG is with a mass of 940.68, HXA = n-hexylammonium ion having a mass of 
102.13, and SO3 is a sulfonate group with a mass of 79.96. (p6:   [(PGG + 12 (SO3-HXA)–12 H) 
+ 2 HXA] 2+). 
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Figure 5.7. ESI-MS spectrum of peak p5 at 11.934 min in the range 200 – 2048 amu using a scan 
time of 0.25 s. PGG is with a mass of 940.68, HXA = n-hexylammonium ion having a mass of 
102.13, and SO3 is a sulfonate group with a mass of 79.96. (p5: [(PGG + 11 (SO3-HXA)–11 H) + 
2 HXA] 2+). 
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Figure 5.8. ESI-MS spectrum of peak p4 at 10.773 min in the range 200 – 2048 amu using a scan 
time of 0.25 s. PGG is with a mass of 940.68, HXA = n-hexylammonium ion having a mass of 
102.13, and SO3 is a sulfonate group with a mass of 79.96. (p4:   [(PGG + 10 (SO3-HXA) – 
10H)+2 HXA] 2+). 
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Figure 5.9. ESI-MS spectrum of peak p3 at 9.934 min in the range 200 – 2048 amu using a scan 
time of 0.25 s. PGG is with a mass of 940.68, HXA = n-hexylammonium ion having a mass of 
102.13, and SO3 is a sulfonate group with a mass of 79.96. (p3: [(PGG + 9 (SO3 - HXA) – 9 H) + 
2 HXA] 2+). 
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Figure 5.10. ESI-MS spectrum of peak p2 at 9.127 min in the range 200 – 2048 amu using a scan 
time of 0.25 s. PGG is with a mass of 940.68, HXA = n-hexylammonium ion having a mass of 
102.13, and SO3 is a sulfonate group with a mass of 79.96. (p2:   [(PGG +8 (SO3-HXA) – 8 H) + 
2 HXA] 2+).  
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Figure 5.11. RPIP UPLC-MS chromatogram of SPGG in the presence of 25 mM HXA (above); 
single ion count chromatogram for peak p4 (below); [PGG + 10 SO3 + 12 HXA] 2+, m/z = 1479. 
Solvent A, water containing 25 mM PTA + 0.1% v/v formic acid; Solvent B, acetonitrile: water 
(3:1) containing 25 mM PTA + 0.1% v/v formic acid; cone voltage, 20 V. 
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Figure 5.12. Mass spectra corresponding to minor peaks a, b, c, d of p4, at cone voltage = 20 V. 
Base peaks in all spectra are of the same m/z ≈ 1479, indicative of positional isomeric peaks.  
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Figure 5.13. Mass spectral fingerprints corresponding to minor peaks a, b, c, d of p4, at cone 
voltage = 60 V.  
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Figure 5.14. Comparison of the UPLC-MS profiles of three batches of SPGG prepared 
independently. 
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Conclusions: 
• Retention and identification of small molecules 1 to 5 as intact ions was achieved 
through reversed-phase ion-pairing UPLC-MS. 
• Comparative analysis showed increments in kʹ values of 1 to 5 with different 
agents as being dependent on number of sulfates. 
• We hypothesize that the number of sulfates in a unknown molecule can be 
identified by slope values obtained by plotting kʹ vs.carbon atom number of ion-
pairing agent. 
• Ion-pairing was found to be more structure-dependent than dependent on carbon 
atom number/alkyl number of ion-pairing agent. 
• Collision-induced dissociation or cone voltage-based fragmentation was 
effectively used in: 
•  identifying  minimum number of sulfates on the molecule 
• the development of unique fragmentation patterns called “fingerprints” 
• the separation of positional isomers and obtained unique MS fingerprints 
for each 
•  identifying unknown compounds as multiply-charged ions 
 182 
• Successfully characterized sulfated pentagalloyl glucopyranoside mixture and 
identified the presence of nona-, deca- and undeca- sulfated SPGG species, 
quantified them relative to the other species. 
• Overall, no derivatization methods such as permethylation were required to obtain 
mass information on sulfated small molecules. 
Future directions: 
With this project, we aim to characterize β-O-4 lignin polymer, a potent selective 
thrombin inhibitor discovered by our lab, as well as, other polydisperse sulfated mixtures 
showing heparin mimetic actions, using ion-pairing UPLC-MS. Another prospective area 
of research would be the study of positional isomers and identification of sulfate group 
positions in GAG oligosaccharides, using up-front CID in MS. Furthermore, to expand 
our panel of ion-pairing agents, polyminoalkanes, such as spermine and spermidine, 
secondary amines, etc. would, in the future, be tested against our library of molecules. In 
the future, we aim to study the interaction of GAG mimetics with ion-pairing agents as a 
representative model of their binding site interactions with ligands in the body. 
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